. (CRY)
- - (-)
Market Cap: -
As of 12/31/69 07:00 PM EST. Market closed.
. (CRY)
-
- (-)
Market Cap: -
As of 12/31/69 07:00 PM EST. Market closed.
Add to Portfolio
... read more
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
-
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
-
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | Mar 20, 2024 | Sale | $20.39 | 2,183 | 44,511 | 83,296 | Mar 21, 2024, 05:14 PM |
| GREEN ANDREW M | VP Regulatory | Mar 15, 2024 | Sale | $20.00 | 1,462 | 29,240 | 41,121 | Mar 18, 2024, 06:09 PM |
| GREEN ANDREW M | VP Regulatory | Mar 14, 2024 | Sale | $20.00 | 3,994 | 79,880 | 42,583 | Mar 15, 2024, 05:20 PM |
| Getz Matthew A | VP, Human Resources | Mar 12, 2024 | Sale | $19.94 | 5,000 | 99,719 | 43,536 | Mar 14, 2024, 09:06 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 26, 2024 | Sale | $20.27 | 2,134 | 43,259 | 137,888 | Mar 14, 2024, 08:38 PM |
| Stanton Marshall S. | SVP, Clinical & MD Affair | Feb 26, 2024 | Sale | $20.27 | 3,007 | 60,955 | 81,726 | Mar 14, 2024, 08:36 PM |
| Maney Rochelle L. | VP, Quality | Feb 26, 2024 | Sale | $20.27 | 2,282 | 46,259 | 44,518 | Mar 14, 2024, 08:33 PM |
| Holloway Jean F | SVP, General Counsel | Feb 26, 2024 | Sale | $20.27 | 2,838 | 57,529 | 166,852 | Mar 14, 2024, 08:31 PM |
| GREEN ANDREW M | VP Regulatory | Feb 26, 2024 | Sale | $20.27 | 2,367 | 47,982 | 44,580 | Mar 14, 2024, 08:29 PM |
| Davis John E | Chief Commercial Officer | Feb 26, 2024 | Sale | $20.27 | 3,461 | 70,158 | 162,572 | Mar 14, 2024, 08:27 PM |
| Stanton Marshall S. | SVP, Clinical & MD Affair | Feb 27, 2024 | Sale | $19.83 | 465 | 9,223 | 81,261 | Mar 14, 2024, 08:25 PM |
| Maney Rochelle L. | VP, Quality | Feb 27, 2024 | Sale | $19.83 | 370 | 7,339 | 44,148 | Mar 14, 2024, 08:23 PM |
| GREEN ANDREW M | VP Regulatory | Feb 27, 2024 | Sale | $19.83 | 421 | 8,350 | 44,159 | Mar 14, 2024, 08:20 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 27, 2024 | Sale | $19.83 | 325 | 6,446 | 137,563 | Mar 14, 2024, 08:18 PM |
| Davis John E | Chief Commercial Officer | Feb 27, 2024 | Sale | $19.83 | 584 | 11,583 | 161,988 | Mar 14, 2024, 08:16 PM |
| Mackin James P | President & CEO | Feb 26, 2024 | Sale | $20.27 | 30,836 | 625,080 | 696,253 | Mar 14, 2024, 08:14 PM |
| Holloway Jean F | SVP, General Counsel | Feb 27, 2024 | Sale | $19.83 | 485 | 9,620 | 166,367 | Mar 14, 2024, 08:11 PM |
| Horton Amy | VP, Chief Accounting Officer | Mar 05, 2024 | Sale | $18.72 | 1,152 | 21,568 | 139,989 | Mar 14, 2024, 08:09 PM |
| Stanton Marshall S. | SVP, Clinical & MD Affair | Mar 01, 2024 | Sale | $18.72 | 1,506 | 28,195 | 85,479 | Mar 14, 2024, 08:06 PM |
| Getz Matthew A | VP, Human Resources | Feb 26, 2024 | Sale | $20.27 | 2,280 | 46,218 | 46,440 | Mar 14, 2024, 08:04 PM |
| Getz Matthew A | VP, Human Resources | Feb 27, 2024 | Sale | $19.83 | 325 | 6,446 | 46,115 | Mar 14, 2024, 08:02 PM |
| Maney Rochelle L. | VP, Quality | Mar 05, 2024 | Sale | $18.72 | 1,157 | 21,662 | 46,569 | Mar 14, 2024, 08:00 PM |
| Mackin James P | President & CEO | Feb 27, 2024 | Sale | $19.83 | 4,837 | 95,939 | 691,416 | Mar 14, 2024, 07:57 PM |
| Holloway Jean F | SVP, General Counsel | Mar 05, 2024 | Sale | $18.72 | 2,380 | 44,559 | 169,711 | Mar 14, 2024, 07:55 PM |
| GREEN ANDREW M | VP Regulatory | Mar 05, 2024 | Sale | $18.72 | 1,160 | 21,718 | 46,577 | Mar 14, 2024, 07:53 PM |
| Getz Matthew A | VP, Human Resources | Mar 05, 2024 | Sale | $18.72 | 1,157 | 21,661 | 48,536 | Mar 14, 2024, 07:51 PM |
| Davis John E | Chief Commercial Officer | Mar 05, 2024 | Sale | $18.72 | 2,022 | 37,856 | 165,690 | Mar 14, 2024, 07:48 PM |
| Mackin James P | President & CEO | Mar 05, 2024 | Sale | $18.72 | 13,996 | 262,037 | 706,038 | Mar 14, 2024, 07:45 PM |
| Mackin James P | President & CEO | Mar 05, 2024 | Sale | $18.72 | 13,996 | 262,037 | 705,562 | Mar 07, 2024, 06:20 PM |
| Holloway Jean F | SVP, General Counsel | Mar 05, 2024 | Sale | $18.72 | 2,380 | 44,559 | 169,669 | Mar 07, 2024, 06:16 PM |
| Davis John E | Chief Commercial Officer | Mar 05, 2024 | Sale | $18.72 | 2,022 | 37,856 | 165,637 | Mar 07, 2024, 06:14 PM |
| Getz Matthew A | VP, Human Resources | Mar 05, 2024 | Sale | $18.72 | 1,157 | 21,661 | 48,503 | Mar 07, 2024, 06:12 PM |
| Maney Rochelle L. | VP, Quality | Mar 05, 2024 | Sale | $18.72 | 1,157 | 21,662 | 46,536 | Mar 07, 2024, 06:10 PM |
| GREEN ANDREW M | VP Regulatory | Mar 05, 2024 | Sale | $18.72 | 1,160 | 21,718 | 46,541 | Mar 07, 2024, 06:07 PM |
| Stanton Marshall S. | SVP, Clinical & MD Affair | Mar 05, 2024 | Sale | $18.72 | 1,506 | 28,195 | 85,438 | Mar 07, 2024, 06:05 PM |
| Horton Amy | VP, Chief Accounting Officer | Mar 05, 2024 | Sale | $18.72 | 1,152 | 21,568 | 139,957 | Mar 07, 2024, 06:01 PM |
| Tyrs Florian | VP, Global Operations | Feb 27, 2024 | Sale | $19.83 | 339 | 6,724 | 21,558 | Feb 29, 2024, 05:43 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 27, 2024 | Sale | $19.83 | 325 | 6,446 | 137,531 | Feb 29, 2024, 05:39 PM |
| Mackin James P | President & CEO | Feb 27, 2024 | Sale | $19.83 | 4,837 | 95,939 | 690,940 | Feb 29, 2024, 05:36 PM |
| Holloway Jean F | SVP, General Counsel | Feb 27, 2024 | Sale | $19.83 | 485 | 9,620 | 166,325 | Feb 29, 2024, 05:34 PM |
| Davis John E | Chief Commercial Officer | Feb 27, 2024 | Sale | $19.83 | 584 | 11,583 | 161,935 | Feb 29, 2024, 05:32 PM |
| Maney Rochelle L. | VP, Quality | Feb 27, 2024 | Sale | $19.83 | 370 | 7,339 | 44,115 | Feb 29, 2024, 05:30 PM |
| Getz Matthew A | VP, Human Resources | Feb 27, 2024 | Sale | $19.83 | 325 | 6,446 | 46,082 | Feb 29, 2024, 05:27 PM |
| GREEN ANDREW M | VP Regulatory | Feb 27, 2024 | Sale | $19.83 | 421 | 8,350 | 44,123 | Feb 29, 2024, 05:21 PM |
| Stanton Marshall S. | SVP, Clinical & MD Affair | Feb 27, 2024 | Sale | $19.83 | 465 | 9,223 | 81,220 | Feb 29, 2024, 05:18 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 26, 2024 | Sale | $20.27 | 2,166 | 43,907 | 137,856 | Feb 28, 2024, 05:25 PM |
| Mackin James P | President & CEO | Feb 26, 2024 | Sale | $20.27 | 31,312 | 634,729 | 695,777 | Feb 28, 2024, 05:22 PM |
| Holloway Jean F | SVP, General Counsel | Feb 26, 2024 | Sale | $20.27 | 2,880 | 58,381 | 166,810 | Feb 28, 2024, 05:18 PM |
| Maney Rochelle L. | VP, Quality | Feb 26, 2024 | Sale | $20.27 | 2,315 | 46,928 | 44,485 | Feb 28, 2024, 05:16 PM |
| Davis John E | Chief Commercial Officer | Feb 26, 2024 | Sale | $20.27 | 3,514 | 71,233 | 162,519 | Feb 28, 2024, 05:12 PM |
| Getz Matthew A | VP, Human Resources | Feb 26, 2024 | Sale | $20.27 | 2,313 | 46,887 | 46,407 | Feb 28, 2024, 05:07 PM |
| GREEN ANDREW M | VP Regulatory | Feb 26, 2024 | Sale | $20.27 | 2,403 | 48,711 | 44,544 | Feb 28, 2024, 05:04 PM |
| Stanton Marshall S. | SVP, Clinical & MD Affair | Feb 26, 2024 | Sale | $20.27 | 3,048 | 61,786 | 81,685 | Feb 28, 2024, 05:01 PM |
| Tyrs Florian | VP, Global Operations | Feb 26, 2024 | Sale | $20.27 | 893 | 18,103 | 21,897 | Feb 28, 2024, 04:58 PM |
| Holloway Jean F | SVP, General Counsel | Feb 20, 2024 | Sale | $18.86 | 3,527 | 66,537 | 133,514 | Feb 22, 2024, 05:37 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 20, 2024 | Sale | $18.86 | 1,695 | 31,976 | 122,711 | Feb 22, 2024, 05:35 PM |
| Davis John E | Chief Commercial Officer | Feb 20, 2024 | Sale | $18.86 | 2,556 | 48,219 | 128,673 | Feb 22, 2024, 05:32 PM |
| Maney Rochelle L. | VP, Quality | Feb 20, 2024 | Sale | $18.86 | 407 | 7,678 | 29,123 | Feb 22, 2024, 05:29 PM |
| Getz Matthew A | VP, Human Resources | Feb 20, 2024 | Sale | $18.86 | 1,695 | 31,976 | 29,058 | Feb 22, 2024, 05:26 PM |
| Tyrs Florian | VP, Global Operations | Feb 20, 2024 | Sale | $18.86 | 249 | 4,697 | 16,253 | Feb 22, 2024, 05:22 PM |
| Mackin James P | President & CEO | Feb 20, 2024 | Option Exercise | $16.30 | 59,225 | 965,367 | 611,105 | Feb 22, 2024, 05:08 PM |
| Mackin James P | President & CEO | Feb 20, 2024 | Sale | $18.85 | 72,069 | 1,358,818 | 551,880 | Feb 22, 2024, 05:08 PM |
| Holloway Jean F | SVP, General Counsel | Jan 02, 2024 | Option Exercise | $16.30 | 21,229 | 346,033 | 154,749 | Jan 04, 2024, 04:25 PM |
| Holloway Jean F | SVP, General Counsel | Jan 02, 2024 | Sale | $18.00 | 21,229 | 382,122 | 133,520 | Jan 04, 2024, 04:25 PM |
| Davis John E | Senior VP, Global Sales | Jan 02, 2024 | Option Exercise | $16.30 | 13,562 | 221,061 | 142,295 | Jan 04, 2024, 04:22 PM |
| Davis John E | Senior VP, Global Sales | Jan 02, 2024 | Sale | $18.00 | 13,562 | 244,116 | 128,733 | Jan 04, 2024, 04:22 PM |
| Horton Amy | VP, Chief Accounting Officer | Dec 15, 2023 | Option Exercise | $16.30 | 14,397 | 234,671 | 138,437 | Dec 19, 2023, 05:23 PM |
| Horton Amy | VP, Chief Accounting Officer | Dec 15, 2023 | Sale | $19.00 | 14,397 | 273,543 | 124,040 | Dec 19, 2023, 05:23 PM |
| Berry Lance A | Executive VP, CFO | Dec 06, 2023 | Option Exercise | $17.83 | 42,064 | 750,001 | 42,064 | Dec 08, 2023, 09:16 AM |
| Horton Amy | VP, Chief Accounting Officer | Dec 06, 2023 | Option Exercise | $17.83 | 20,191 | 360,006 | 124,040 | Dec 08, 2023, 09:09 AM |
| Horton Amy | VP, Chief Accounting Officer | Nov 27, 2023 | Option Exercise | $17.51 | 1,750 | 30,643 | 103,849 | Nov 29, 2023, 09:15 AM |
| Horton Amy | VP, Chief Accounting Officer | Nov 27, 2023 | Sale | $17.34 | 2,101 | 36,431 | 105,599 | Nov 29, 2023, 09:15 AM |
| Tyrs Florian | VP, Global Operations | Aug 08, 2023 | Option Exercise | $16.79 | 2,107 | 35,377 | 16,502 | Aug 10, 2023, 08:48 AM |
| THOMSON ROBERT C | VP Research & Development | Jun 09, 2023 | Option Exercise | $15.49 | 5,126 | 79,402 | 5,126 | Jun 12, 2023, 09:46 PM |
| Maier Dennis B | SVP, Operations | Jun 06, 2023 | Sale | $15.27 | 16,254 | 248,163 | 35,102 | Jun 08, 2023, 05:24 PM |
| Getz Matthew A | VP, Human Resources | Jun 07, 2023 | Sale | $15.88 | 6,329 | 100,483 | 30,387 | Jun 08, 2023, 05:20 PM |
| Maier Dennis B | SVP, Operations | Mar 02, 2023 | Sale | $13.41 | 1,121 | 15,035 | 50,978 | Mar 03, 2023, 06:20 PM |
| Maney Rochelle L. | VP, Quality | Mar 02, 2023 | Sale | $13.41 | 821 | 11,011 | 29,530 | Mar 03, 2023, 06:18 PM |
| Horton Amy | VP, Chief Accounting Officer | Mar 02, 2023 | Sale | $13.41 | 702 | 9,415 | 107,700 | Mar 03, 2023, 06:13 PM |
| Getz Matthew A | VP, Human Resources | Mar 02, 2023 | Sale | $13.41 | 702 | 9,415 | 36,716 | Mar 03, 2023, 06:11 PM |
| Mackin James P | President & CEO | Mar 02, 2023 | Sale | $13.41 | 9,990 | 133,984 | 551,880 | Mar 03, 2023, 06:07 PM |
| GREEN ANDREW M | VP Regulatory | Mar 02, 2023 | Sale | $13.41 | 825 | 11,065 | 25,567 | Mar 03, 2023, 06:05 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Mar 02, 2023 | Sale | $13.41 | 1,401 | 18,790 | 347,217 | Mar 03, 2023, 06:01 PM |
| Stanton Marshall S. | SVP, Clinical & MD Affair | Mar 02, 2023 | Sale | $13.41 | 907 | 12,165 | 52,077 | Mar 03, 2023, 05:56 PM |
| Davis John E | Senior VP, Global Sales | Mar 02, 2023 | Sale | $13.41 | 1,121 | 15,035 | 128,733 | Mar 03, 2023, 05:52 PM |
| Holloway Jean F | SVP, General Counsel | Mar 02, 2023 | Sale | $13.41 | 907 | 12,165 | 133,520 | Mar 03, 2023, 05:48 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 27, 2023 | Sale | $12.94 | 1,419 | 18,359 | 106,112 | Mar 01, 2023, 06:52 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 27, 2023 | Sale | $12.94 | 3,094 | 40,030 | 344,039 | Mar 01, 2023, 06:49 PM |
| Holloway Jean F | SVP, General Counsel | Feb 27, 2023 | Sale | $12.94 | 1,960 | 25,358 | 130,764 | Mar 01, 2023, 06:46 PM |
| Davis John E | Senior VP, Global Sales | Feb 27, 2023 | Sale | $12.94 | 2,393 | 30,961 | 126,191 | Mar 01, 2023, 06:44 PM |
| Maney Rochelle L. | VP, Quality | Feb 27, 2023 | Option Exercise | $12.94 | 790 | 10,221 | 28,467 | Mar 01, 2023, 06:41 PM |
| Maney Rochelle L. | VP, Quality | Feb 27, 2023 | Sale | $12.94 | 878 | 11,360 | 25,017 | Mar 01, 2023, 06:41 PM |
| Maney Rochelle L. | VP, Quality | Feb 28, 2023 | Sale | $13.24 | 406 | 5,374 | 28,061 | Mar 01, 2023, 06:41 PM |
| GREEN ANDREW M | VP Regulatory | Feb 27, 2023 | Sale | $12.94 | 1,747 | 22,603 | 24,102 | Mar 01, 2023, 06:39 PM |
| Mackin James P | President & CEO | Feb 27, 2023 | Sale | $12.94 | 22,630 | 292,787 | 540,052 | Mar 01, 2023, 06:36 PM |
| Maier Dennis B | SVP, Operations | Feb 27, 2023 | Sale | $12.94 | 2,330 | 30,146 | 48,436 | Mar 01, 2023, 06:32 PM |
| Stanton Marshall S. | SVP, Clinical & MD Affair | Feb 27, 2023 | Sale | $12.94 | 2,337 | 30,236 | 49,321 | Mar 01, 2023, 06:27 PM |
| Getz Matthew A | VP, Human Resources | Feb 27, 2023 | Sale | $12.94 | 1,600 | 20,701 | 35,128 | Mar 01, 2023, 06:22 PM |
| Getz Matthew A | VP, Human Resources | Feb 19, 2023 | Option Exercise | $13.96 | 1,407 | 19,642 | 30,414 | Feb 21, 2023, 08:52 AM |
| Getz Matthew A | VP, Human Resources | Feb 17, 2023 | Option Exercise | $13.96 | 363 | 5,067 | 31,539 | Feb 21, 2023, 08:52 AM |
| Holloway Jean F | SVP, General Counsel | Feb 19, 2023 | Option Exercise | $13.96 | 1,700 | 23,732 | 121,539 | Feb 21, 2023, 08:49 AM |
| Holloway Jean F | SVP, General Counsel | Feb 17, 2023 | Option Exercise | $13.96 | 1,985 | 27,711 | 124,327 | Feb 21, 2023, 08:49 AM |
| Maney Rochelle L. | VP, Quality | Feb 17, 2023 | Option Exercise | $13.96 | 403 | 5,626 | 23,539 | Feb 21, 2023, 08:46 AM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 19, 2023 | Option Exercise | $13.96 | 2,630 | 36,715 | 332,824 | Feb 21, 2023, 08:40 AM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 17, 2023 | Option Exercise | $13.96 | 635 | 8,865 | 334,928 | Feb 21, 2023, 08:40 AM |
| Maier Dennis B | SVP, Operations | Feb 19, 2023 | Option Exercise | $13.96 | 1,407 | 19,642 | 40,960 | Feb 21, 2023, 08:36 AM |
| Maier Dennis B | SVP, Operations | Feb 17, 2023 | Option Exercise | $13.96 | 380 | 5,305 | 42,085 | Feb 21, 2023, 08:36 AM |
| Horton Amy | VP, Chief Accounting Officer | Feb 19, 2023 | Option Exercise | $13.96 | 1,365 | 19,055 | 101,193 | Feb 21, 2023, 08:33 AM |
| Horton Amy | VP, Chief Accounting Officer | Feb 17, 2023 | Option Exercise | $13.96 | 363 | 5,067 | 102,300 | Feb 21, 2023, 08:33 AM |
| Horton Amy | VP, Chief Accounting Officer | Feb 17, 2023 | Option Exercise | $10.24 | 20,713 | 212,101 | 117,663 | Feb 21, 2023, 08:33 AM |
| Horton Amy | VP, Chief Accounting Officer | Feb 17, 2023 | Sale | $14.09 | 18,000 | 253,553 | 102,663 | Feb 21, 2023, 08:33 AM |
| Mackin James P | President & CEO | Feb 17, 2023 | Option Exercise | $13.96 | 2,740 | 38,250 | 502,944 | Feb 21, 2023, 08:29 AM |
| Mackin James P | President & CEO | Feb 19, 2023 | Option Exercise | $13.96 | 10,692 | 149,260 | 494,391 | Feb 21, 2023, 08:29 AM |
| Davis John E | Senior VP, Global Sales | Feb 19, 2023 | Option Exercise | $13.96 | 2,247 | 31,368 | 117,574 | Feb 21, 2023, 08:26 AM |
| Davis John E | Senior VP, Global Sales | Feb 17, 2023 | Option Exercise | $13.96 | 586 | 8,181 | 119,431 | Feb 21, 2023, 08:26 AM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 14, 2023 | Option Exercise | $10.24 | 36,822 | 377,057 | 367,463 | Feb 16, 2023, 05:41 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 14, 2023 | Sale | $13.22 | 31,900 | 421,874 | 335,563 | Feb 16, 2023, 05:41 PM |
| Mackin James P | President & CEO | Feb 14, 2023 | Option Exercise | $10.24 | 65,549 | 671,222 | 562,184 | Feb 16, 2023, 05:36 PM |
| Mackin James P | President & CEO | Feb 14, 2023 | Sale | $13.22 | 56,500 | 747,207 | 505,684 | Feb 16, 2023, 05:36 PM |
| Davis John E | Senior VP, Global Sales | Feb 13, 2023 | Option Exercise | $10.24 | 8,745 | 89,549 | 120,017 | Feb 15, 2023, 08:48 AM |
| Horton Amy | VP, Chief Accounting Officer | Dec 14, 2022 | Option Exercise | $13.21 | 2,000 | 26,420 | 99,950 | Dec 16, 2022, 08:35 AM |
| Horton Amy | VP, Chief Accounting Officer | Dec 14, 2022 | Sale | $13.57 | 3,226 | 43,783 | 101,950 | Dec 16, 2022, 08:35 AM |
| Maney Rochelle L. | VP, Quality | Nov 04, 2022 | Option Exercise | $11.18 | 214 | 2,393 | 12,111 | Nov 07, 2022, 04:53 PM |
| Maney Rochelle L. | VP, Quality | Aug 16, 2022 | Sale | $22.96 | 7,161 | 164,409 | 12,325 | Aug 18, 2022, 04:24 PM |
| Maier Dennis B | SVP, Operations | Aug 09, 2022 | Sale | $21.61 | 5,762 | 124,513 | 28,424 | Aug 10, 2022, 05:12 PM |
| SEMEDO ANTHONY B. | Director | Jun 01, 2022 | Option Exercise | $19.04 | 7,878 | 149,997 | 27,870 | Jun 03, 2022, 04:48 PM |
| Salveson Jon W | Director | Jun 01, 2022 | Option Exercise | $19.04 | 7,878 | 149,997 | 107,517 | Jun 03, 2022, 04:46 PM |
| Burbank Jeffrey H | Director | Jun 01, 2022 | Option Exercise | $19.04 | 7,878 | 149,997 | 31,473 | Jun 03, 2022, 04:45 PM |
| Bullock James | Director | Jun 01, 2022 | Option Exercise | $19.04 | 7,878 | 149,997 | 46,324 | Jun 03, 2022, 04:39 PM |
| Borgstrom Marna P | Director | Jun 01, 2022 | Option Exercise | $19.04 | 7,878 | 149,997 | 26,765 | Jun 03, 2022, 04:36 PM |
| BEVEVINO DANIEL J | Director | Jun 01, 2022 | Option Exercise | $19.04 | 7,878 | 149,997 | 127,738 | Jun 03, 2022, 04:34 PM |
| ACKERMAN THOMAS F | Director | Jun 01, 2022 | Option Exercise | $19.04 | 7,878 | 149,997 | 127,573 | Jun 03, 2022, 04:31 PM |
| Maney Rochelle L. | VP, Quality | Mar 08, 2022 | Option Exercise | $20.32 | 81 | 1,646 | 19,486 | Mar 09, 2022, 04:45 PM |
| Barthold Franz Peter | VP, Research & Development | Mar 08, 2022 | Option Exercise | $20.32 | 76 | 1,544 | 20,005 | Mar 09, 2022, 04:44 PM |
| Maier Dennis B | Vice President, Operations | Mar 05, 2022 | Option Exercise | $21.69 | 1,090 | 23,642 | 28,739 | Mar 07, 2022, 04:34 PM |
| Mackin James P | President & CEO | Mar 05, 2022 | Option Exercise | $21.69 | 13,029 | 282,599 | 381,909 | Mar 07, 2022, 04:33 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Mar 05, 2022 | Option Exercise | $21.69 | 2,146 | 46,547 | 294,290 | Mar 07, 2022, 04:31 PM |
| Horton Amy | VP, Chief Accounting Officer | Mar 05, 2022 | Option Exercise | $21.69 | 1,132 | 24,553 | 93,537 | Mar 07, 2022, 04:27 PM |
| Holloway Jean F | SVP, General Counsel | Mar 05, 2022 | Option Exercise | $21.69 | 1,799 | 39,020 | 101,502 | Mar 07, 2022, 04:22 PM |
| Davis John E | Senior VP, Global Sales | Mar 05, 2022 | Option Exercise | $21.69 | 1,799 | 39,020 | 88,049 | Mar 07, 2022, 04:20 PM |
| Barthold Franz Peter | VP, Research & Development | Mar 05, 2022 | Option Exercise | $21.69 | 602 | 13,057 | 20,184 | Mar 07, 2022, 04:17 PM |
| Maney Rochelle L. | VP, Quality | Feb 27, 2022 | Option Exercise | $19.35 | 398 | 7,701 | 19,567 | Mar 01, 2022, 05:02 PM |
| Maier Dennis B | Vice President, Operations | Feb 19, 2022 | Option Exercise | $17.75 | 282 | 5,006 | 22,519 | Feb 22, 2022, 05:02 PM |
| Mackin James P | President & CEO | Feb 19, 2022 | Option Exercise | $17.75 | 3,204 | 56,871 | 345,083 | Feb 22, 2022, 05:00 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 19, 2022 | Option Exercise | $17.75 | 526 | 9,337 | 284,632 | Feb 22, 2022, 04:59 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 19, 2022 | Option Exercise | $17.75 | 256 | 4,544 | 89,687 | Feb 22, 2022, 04:57 PM |
| Holloway Jean F | SVP, General Counsel | Feb 19, 2022 | Option Exercise | $17.75 | 421 | 7,473 | 94,226 | Feb 22, 2022, 04:56 PM |
| Getz Matthew A | VP, Human Resources | Feb 19, 2022 | Option Exercise | $17.75 | 244 | 4,331 | 13,921 | Feb 22, 2022, 04:55 PM |
| Davis John E | Senior VP, Global Sales | Feb 19, 2022 | Option Exercise | $17.75 | 402 | 7,136 | 80,917 | Feb 22, 2022, 04:53 PM |
| Barthold Franz Peter | VP, Research & Development | Feb 19, 2022 | Option Exercise | $17.75 | 353 | 6,266 | 15,893 | Feb 22, 2022, 04:52 PM |
| Stanton Marshall S. | SVP, Clinical & MD Affair | Feb 17, 2022 | Option Exercise | $17.50 | 772 | 13,510 | 11,342 | Feb 22, 2022, 07:33 AM |
| Maney Rochelle L. | VP, Quality | Feb 17, 2022 | Option Exercise | $17.50 | 979 | 17,133 | 15,175 | Feb 22, 2022, 07:32 AM |
| Maier Dennis B | Vice President, Operations | Feb 17, 2022 | Option Exercise | $17.50 | 1,463 | 25,603 | 22,801 | Feb 22, 2022, 07:31 AM |
| Mackin James P | President & CEO | Feb 17, 2022 | Option Exercise | $17.50 | 16,133 | 282,328 | 348,287 | Feb 22, 2022, 07:30 AM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 17, 2022 | Option Exercise | $17.50 | 2,514 | 43,995 | 285,158 | Feb 22, 2022, 07:29 AM |
| Horton Amy | VP, Chief Accounting Officer | Feb 17, 2022 | Option Exercise | $17.50 | 1,418 | 24,815 | 89,943 | Feb 22, 2022, 07:28 AM |
| Holloway Jean F | SVP, General Counsel | Feb 17, 2022 | Option Exercise | $17.50 | 3,579 | 62,633 | 96,078 | Feb 22, 2022, 07:27 AM |
| Getz Matthew A | VP, Human Resources | Feb 17, 2022 | Option Exercise | $17.50 | 1,428 | 24,990 | 14,165 | Feb 22, 2022, 07:26 AM |
| Davis John E | Senior VP, Global Sales | Feb 17, 2022 | Option Exercise | $17.50 | 2,035 | 35,613 | 81,319 | Feb 22, 2022, 07:24 AM |
| GREEN ANDREW M | VP Regulatory | Feb 17, 2022 | Option Exercise | $17.50 | 576 | 10,080 | 1,051 | Feb 22, 2022, 07:23 AM |
| Barthold Franz Peter | VP, Research & Development | Feb 17, 2022 | Option Exercise | $17.50 | 1,757 | 30,748 | 16,246 | Feb 22, 2022, 07:22 AM |
| Mackin James P | President & CEO | Feb 09, 2022 | Option Exercise | $11.00 | 10,638 | 117,018 | 314,816 | Feb 11, 2022, 08:41 AM |
| Mackin James P | President & CEO | Feb 10, 2022 | Option Exercise | $11.00 | 10,639 | 117,029 | 314,817 | Feb 11, 2022, 08:41 AM |
| Mackin James P | President & CEO | Feb 09, 2022 | Sale | $18.14 | 10,638 | 192,989 | 304,178 | Feb 11, 2022, 08:41 AM |
| Mackin James P | President & CEO | Feb 10, 2022 | Sale | $17.86 | 10,639 | 189,998 | 304,178 | Feb 11, 2022, 08:41 AM |
| Mackin James P | President & CEO | Feb 08, 2022 | Option Exercise | $11.00 | 10,638 | 117,018 | 314,816 | Feb 10, 2022, 07:53 AM |
| Mackin James P | President & CEO | Feb 08, 2022 | Sale | $17.75 | 10,638 | 188,771 | 304,178 | Feb 10, 2022, 07:53 AM |
| Mackin James P | President & CEO | Feb 07, 2022 | Option Exercise | $11.00 | 10,638 | 117,018 | 314,816 | Feb 08, 2022, 04:38 PM |
| Mackin James P | President & CEO | Feb 07, 2022 | Sale | $17.30 | 10,638 | 184,052 | 304,178 | Feb 08, 2022, 04:38 PM |
| Horton Amy | VP, Chief Accounting Officer | Dec 09, 2021 | Option Exercise | $18.82 | 1,500 | 28,230 | 85,282 | Dec 10, 2021, 04:13 PM |
| Horton Amy | VP, Chief Accounting Officer | Dec 08, 2021 | Sale | $18.57 | 2,500 | 46,422 | 86,782 | Dec 10, 2021, 04:13 PM |
| Davis John E | Senior VP, Global Sales | Nov 29, 2021 | Buy | $17.33 | 600 | 10,398 | 72,499 | Dec 01, 2021, 04:14 PM |
| SEMEDO ANTHONY B. | Director | Nov 29, 2021 | Option Exercise | $17.36 | 4,992 | 86,661 | 4,992 | Nov 30, 2021, 04:40 PM |
| SEMEDO ANTHONY B. | Director | Nov 29, 2021 | Buy | $17.36 | 15,000 | 260,400 | 19,992 | Nov 30, 2021, 04:40 PM |
| Maney Rochelle L. | VP, Quality | Nov 04, 2021 | Option Exercise | $21.21 | 214 | 4,539 | 14,108 | Nov 05, 2021, 04:30 PM |
| Holloway Jean F | SVP, General Counsel | Aug 31, 2021 | Sale | $26.49 | 663 | 17,566 | 86,567 | Sep 01, 2021, 04:14 PM |
| McCall Ronald D | Director | Aug 25, 2021 | Sale | $25.63 | 5,667 | 145,266 | 121,768 | Aug 26, 2021, 04:13 PM |
| Maier Dennis B | Vice President, Operations | Aug 23, 2021 | Sale | $25.64 | 2,715 | 69,613 | 17,677 | Aug 24, 2021, 05:15 PM |
| McCall Ronald D | Director | Jun 01, 2021 | Option Exercise | $29.39 | 4,423 | 129,992 | 127,435 | Jun 02, 2021, 04:25 PM |
| Davis John E | Senior VP, Global Sales | May 25, 2021 | Option Exercise | $26.24 | 5,402 | 141,748 | 84,638 | May 27, 2021, 05:02 PM |
| Davis John E | Senior VP, Global Sales | May 25, 2021 | Sale | $29.66 | 12,739 | 377,880 | 79,236 | May 27, 2021, 05:02 PM |
| Horton Amy | VP, Chief Accounting Officer | May 06, 2021 | Option Exercise | $11.00 | 5,731 | 63,041 | 95,013 | May 10, 2021, 08:29 AM |
| Horton Amy | VP, Chief Accounting Officer | May 06, 2021 | Sale | $30.00 | 5,731 | 171,930 | 89,282 | May 10, 2021, 08:29 AM |
| Holloway Jean F | SVP, General Counsel | May 06, 2021 | Option Exercise | $10.24 | 6,618 | 67,768 | 93,848 | May 10, 2021, 08:28 AM |
| Holloway Jean F | SVP, General Counsel | May 06, 2021 | Sale | $30.50 | 6,618 | 201,849 | 87,230 | May 10, 2021, 08:28 AM |
| Maier Dennis B | Vice President, Operations | Mar 12, 2021 | Option Exercise | $25.05 | 1,385 | 34,694 | 21,172 | Mar 15, 2021, 04:29 PM |
| Mackin James P | President & CEO | Mar 12, 2021 | Option Exercise | $25.05 | 15,766 | 394,938 | 306,852 | Mar 15, 2021, 04:29 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Mar 12, 2021 | Option Exercise | $25.05 | 3,074 | 77,004 | 293,198 | Mar 15, 2021, 04:27 PM |
| Horton Amy | VP, Chief Accounting Officer | Mar 12, 2021 | Option Exercise | $25.05 | 1,739 | 43,562 | 89,573 | Mar 15, 2021, 04:25 PM |
| Holloway Jean F | SVP, General Counsel | Mar 12, 2021 | Option Exercise | $25.05 | 2,682 | 67,184 | 87,677 | Mar 15, 2021, 04:24 PM |
| Davis John E | Senior VP, Global Sales | Mar 12, 2021 | Option Exercise | $25.05 | 2,236 | 56,012 | 79,609 | Mar 15, 2021, 04:21 PM |
| Capps Scott B | VP, Clinical Research | Mar 12, 2021 | Option Exercise | $25.05 | 1,393 | 34,895 | 153,436 | Mar 15, 2021, 04:19 PM |
| Holloway Jean F | SVP, General Counsel | Mar 10, 2021 | Sale | $25.28 | 1,693 | 42,797 | 89,912 | Mar 11, 2021, 04:20 PM |
| Barthold Franz Peter | VP, Research & Development | Mar 08, 2021 | Option Exercise | $24.30 | 76 | 1,847 | 12,121 | Mar 10, 2021, 04:07 PM |
| Simpson Michael S | SVP, Regulatory Affairs and QA | Mar 05, 2021 | Option Exercise | $24.44 | 304 | 7,430 | 33,698 | Mar 10, 2021, 07:51 AM |
| Maier Dennis B | Vice President, Operations | Mar 05, 2021 | Option Exercise | $24.44 | 205 | 5,010 | 22,324 | Mar 10, 2021, 07:46 AM |
| Mackin James P | President & CEO | Mar 05, 2021 | Option Exercise | $24.44 | 1,487 | 36,342 | 319,944 | Mar 10, 2021, 07:44 AM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Mar 05, 2021 | Option Exercise | $24.44 | 359 | 8,774 | 295,759 | Mar 10, 2021, 07:43 AM |
| Horton Amy | VP, Chief Accounting Officer | Mar 05, 2021 | Option Exercise | $24.44 | 226 | 5,523 | 91,021 | Mar 10, 2021, 07:39 AM |
| Holloway Jean F | SVP, General Counsel | Mar 05, 2021 | Option Exercise | $24.44 | 299 | 7,308 | 91,605 | Mar 10, 2021, 07:34 AM |
| Davis John E | Senior VP, Global Sales | Mar 05, 2021 | Option Exercise | $24.44 | 315 | 7,699 | 81,472 | Mar 10, 2021, 07:31 AM |
| Capps Scott B | VP, Clinical Research | Mar 05, 2021 | Option Exercise | $24.44 | 205 | 5,010 | 154,596 | Mar 10, 2021, 07:28 AM |
| Barthold Franz Peter | VP, Research & Development | Mar 05, 2021 | Option Exercise | $24.44 | 103 | 2,517 | 12,197 | Mar 10, 2021, 07:27 AM |
| Horton Amy | VP, Chief Accounting Officer | Mar 01, 2021 | Sale | $25.53 | 13,619 | 347,711 | 91,247 | Mar 02, 2021, 04:41 PM |
| Simpson Michael S | SVP, Regulatory Affairs and QA | Feb 23, 2021 | Option Exercise | $25.41 | 900 | 22,869 | 34,002 | Feb 25, 2021, 05:59 PM |
| Maier Dennis B | Vice President, Operations | Feb 23, 2021 | Option Exercise | $25.41 | 563 | 14,306 | 22,529 | Feb 25, 2021, 05:58 PM |
| Mackin James P | President & CEO | Feb 23, 2021 | Option Exercise | $25.41 | 4,383 | 111,372 | 321,431 | Feb 25, 2021, 05:56 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 23, 2021 | Option Exercise | $25.41 | 1,237 | 31,432 | 296,118 | Feb 25, 2021, 05:55 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 23, 2021 | Option Exercise | $25.41 | 619 | 15,729 | 104,866 | Feb 25, 2021, 05:53 PM |
| Holloway Jean F | VP, General Counsel | Feb 23, 2021 | Option Exercise | $25.41 | 990 | 25,156 | 91,904 | Feb 25, 2021, 05:49 PM |
| Getz Matthew A | VP, Human Resources | Feb 23, 2021 | Option Exercise | $25.41 | 563 | 14,306 | 9,514 | Feb 25, 2021, 05:47 PM |
| Davis John E | Senior VP, Global Sales | Feb 23, 2021 | Option Exercise | $25.41 | 945 | 24,012 | 81,787 | Feb 25, 2021, 05:44 PM |
| Capps Scott B | VP, Clinical Research | Feb 23, 2021 | Option Exercise | $25.41 | 563 | 14,306 | 154,801 | Feb 25, 2021, 05:42 PM |
| Barthold Franz Peter | VP, Research & Development | Feb 23, 2021 | Option Exercise | $25.41 | 704 | 17,889 | 12,300 | Feb 25, 2021, 05:41 PM |
| Maier Dennis B | Vice President, Operations | Feb 17, 2021 | Option Exercise | $21.55 | 6,630 | 142,876 | 23,211 | Feb 19, 2021, 04:28 PM |
| Maier Dennis B | Vice President, Operations | Feb 17, 2021 | Sale | $24.73 | 7,197 | 177,956 | 16,581 | Feb 19, 2021, 04:28 PM |
| Capps Scott B | VP, Clinical Research | Dec 15, 2020 | Option Exercise | $9.97 | 10,000 | 99,700 | 157,006 | Dec 16, 2020, 04:27 PM |
| Capps Scott B | VP, Clinical Research | Dec 15, 2020 | Sale | $21.34 | 8,366 | 178,553 | 148,640 | Dec 16, 2020, 04:27 PM |
| Horton Amy | VP, Chief Accounting Officer | Dec 14, 2020 | Option Exercise | $21.25 | 1,375 | 29,219 | 98,267 | Dec 16, 2020, 08:39 AM |
| Horton Amy | VP, Chief Accounting Officer | Dec 14, 2020 | Option Exercise | $9.97 | 6,666 | 66,460 | 99,642 | Dec 16, 2020, 08:39 AM |
| McCall Ronald D | Director | Dec 14, 2020 | Sale | $21.79 | 4,638 | 101,069 | 128,795 | Dec 15, 2020, 04:38 PM |
| Maier Dennis B | Vice President, Operations | Dec 14, 2020 | Sale | $21.85 | 1,843 | 40,270 | 16,240 | Dec 15, 2020, 04:37 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Dec 10, 2020 | Option Exercise | $9.97 | 16,666 | 166,160 | 299,233 | Dec 14, 2020, 04:27 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Dec 10, 2020 | Sale | $23.00 | 16,666 | 383,318 | 282,567 | Dec 14, 2020, 04:27 PM |
| Barthold Franz Peter | VP, Research & Development | Dec 01, 2020 | Option Exercise | $20.93 | 654 | 13,688 | 6,280 | Dec 03, 2020, 04:31 PM |
| Horton Amy | VP, Chief Accounting Officer | Dec 01, 2020 | Option Exercise | $9.97 | 6,666 | 66,460 | 99,642 | Dec 02, 2020, 04:59 PM |
| Horton Amy | VP, Chief Accounting Officer | Dec 01, 2020 | Sale | $20.78 | 6,666 | 138,503 | 92,976 | Dec 02, 2020, 04:59 PM |
| Maier Dennis B | Vice President, Operations | Nov 02, 2020 | Option Exercise | $17.62 | 1,585 | 27,928 | 18,083 | Nov 04, 2020, 05:06 PM |
| Mackin James P | President & CEO | Sep 16, 2020 | Buy | $16.74 | 7,500 | 125,524 | 264,274 | Oct 01, 2020, 09:00 AM |
| Davis John E | Senior VP, Global Sales | Sep 16, 2020 | Buy | $16.65 | 10,000 | 166,459 | 70,451 | Sep 17, 2020, 05:53 PM |
| Bullock James | Director | Sep 16, 2020 | Buy | $16.63 | 10,000 | 166,273 | 34,023 | Sep 17, 2020, 05:50 PM |
| Mackin James P | President & CEO | Sep 16, 2020 | Option Exercise | $16.74 | 7,500 | 125,524 | 264,274 | Sep 16, 2020, 01:23 PM |
| Salveson Jon W | Director | Jun 01, 2020 | Option Exercise | $22.94 | 5,667 | 130,001 | 95,216 | Jun 02, 2020, 04:50 PM |
| MORGAN HARVEY | Director | Jun 01, 2020 | Option Exercise | $22.94 | 5,667 | 130,001 | 52,070 | Jun 02, 2020, 04:49 PM |
| McCall Ronald D | Director | Jun 01, 2020 | Option Exercise | $22.94 | 5,667 | 130,001 | 133,433 | Jun 02, 2020, 04:47 PM |
| Burbank Jeffrey H | Director | Jun 01, 2020 | Option Exercise | $22.94 | 5,667 | 130,001 | 19,172 | Jun 02, 2020, 04:45 PM |
| Bullock James | Director | Jun 01, 2020 | Option Exercise | $22.94 | 5,667 | 130,001 | 24,023 | Jun 02, 2020, 04:44 PM |
| Borgstrom Marna P | Director | Jun 01, 2020 | Option Exercise | $22.94 | 5,667 | 130,001 | 14,464 | Jun 02, 2020, 04:42 PM |
| BEVEVINO DANIEL J | Director | Jun 01, 2020 | Option Exercise | $22.94 | 5,667 | 130,001 | 115,437 | Jun 02, 2020, 04:41 PM |
| ACKERMAN THOMAS F | Director | Jun 01, 2020 | Option Exercise | $22.94 | 5,667 | 130,001 | 115,272 | Jun 02, 2020, 04:38 PM |
| Horton Amy | VP, Chief Accounting Officer | May 28, 2020 | Sale | $23.81 | 3,000 | 71,415 | 99,642 | May 29, 2020, 08:06 AM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | May 22, 2020 | Option Exercise | $22.86 | 125 | 2,858 | 282,567 | May 27, 2020, 05:50 PM |
| McCall Ronald D | Director | May 05, 2020 | Sale | $22.82 | 1,719 | 39,219 | 127,766 | May 07, 2020, 05:14 PM |
| Maier Dennis B | Vice President, Operations | Mar 12, 2020 | Option Exercise | $20.24 | 226 | 4,574 | 19,668 | Mar 16, 2020, 07:53 AM |
| Mackin James P | President & CEO | Mar 12, 2020 | Option Exercise | $20.24 | 2,674 | 54,122 | 256,774 | Mar 16, 2020, 07:52 AM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Mar 12, 2020 | Option Exercise | $20.24 | 513 | 10,383 | 282,692 | Mar 16, 2020, 07:50 AM |
| Horton Amy | VP, Chief Accounting Officer | Mar 12, 2020 | Option Exercise | $20.24 | 292 | 5,910 | 102,642 | Mar 16, 2020, 07:48 AM |
| Holloway Jean F | VP, General Counsel | Mar 12, 2020 | Option Exercise | $20.24 | 447 | 9,047 | 65,051 | Mar 16, 2020, 07:46 AM |
| Davis John E | Senior VP, Global Sales | Mar 12, 2020 | Option Exercise | $20.24 | 373 | 7,550 | 60,451 | Mar 16, 2020, 07:43 AM |
| Capps Scott B | VP, Clinical Research | Mar 12, 2020 | Option Exercise | $20.24 | 233 | 4,716 | 147,006 | Mar 16, 2020, 07:38 AM |
| Bogenschuetz Thomas J | VP, EMEA & General Manager | Mar 12, 2020 | Option Exercise | $20.24 | 337 | 6,821 | 23,451 | Mar 16, 2020, 07:37 AM |
| Simpson Michael S | SVP, Regulatory Affairs and QA | Mar 05, 2020 | Option Exercise | $24.93 | 658 | 16,404 | 24,387 | Mar 09, 2020, 04:18 PM |
| Maier Dennis B | Vice President, Operations | Mar 05, 2020 | Option Exercise | $24.93 | 411 | 10,246 | 19,894 | Mar 09, 2020, 04:15 PM |
| Mackin James P | President & CEO | Mar 05, 2020 | Option Exercise | $24.93 | 4,455 | 111,063 | 273,448 | Mar 09, 2020, 04:14 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Mar 05, 2020 | Option Exercise | $24.93 | 734 | 18,299 | 287,305 | Mar 09, 2020, 04:13 PM |
| Horton Amy | VP, Chief Accounting Officer | Mar 05, 2020 | Option Exercise | $24.93 | 385 | 9,598 | 105,234 | Mar 09, 2020, 04:11 PM |
| Holloway Jean F | VP, General Counsel | Mar 05, 2020 | Option Exercise | $24.93 | 615 | 15,332 | 68,888 | Mar 09, 2020, 04:10 PM |
| Davis John E | Senior VP, Global Sales | Mar 05, 2020 | Option Exercise | $24.93 | 615 | 15,332 | 64,072 | Mar 09, 2020, 04:08 PM |
| Capps Scott B | VP, Clinical Research | Mar 05, 2020 | Option Exercise | $24.93 | 350 | 8,726 | 149,237 | Mar 09, 2020, 04:07 PM |
| Bogenschuetz Thomas J | VP, EMEA & General Manager | Mar 05, 2020 | Option Exercise | $24.93 | 911 | 22,711 | 23,788 | Mar 09, 2020, 04:05 PM |
| McCall Ronald D | Director | Feb 24, 2020 | Sale | $26.05 | 4,734 | 123,340 | 127,865 | Feb 25, 2020, 04:38 PM |
| Mackin James P | President & CEO | Feb 21, 2020 | Option Exercise | $26.20 | 9,999 | 261,974 | 258,147 | Feb 25, 2020, 04:37 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 21, 2020 | Option Exercise | $26.20 | 2,057 | 53,893 | 103,065 | Feb 25, 2020, 04:34 PM |
| Holloway Jean F | VP, General Counsel | Feb 21, 2020 | Option Exercise | $26.20 | 2,780 | 72,836 | 65,419 | Feb 25, 2020, 04:33 PM |
| Davis John E | Senior VP, Global Sales | Feb 21, 2020 | Option Exercise | $26.20 | 2,817 | 73,805 | 60,603 | Feb 25, 2020, 04:31 PM |
| Capps Scott B | VP, Clinical Research | Feb 21, 2020 | Option Exercise | $26.20 | 1,802 | 47,212 | 147,267 | Feb 25, 2020, 04:30 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 21, 2020 | Option Exercise | $26.20 | 3,487 | 91,359 | 283,165 | Feb 25, 2020, 12:00 AM |
| Holloway Jean F | VP, General Counsel | Jan 21, 2020 | Option Exercise | $9.64 | 8,458 | 81,535 | 67,322 | Jan 23, 2020, 04:13 PM |
| Holloway Jean F | VP, General Counsel | Jan 21, 2020 | Sale | $30.00 | 8,458 | 253,744 | 58,864 | Jan 23, 2020, 04:13 PM |
| Holloway Jean F | VP, General Counsel | Jan 16, 2020 | Option Exercise | $9.64 | 195 | 1,880 | 59,059 | Jan 21, 2020, 04:28 PM |
| Holloway Jean F | VP, General Counsel | Jan 16, 2020 | Sale | $30.00 | 195 | 5,850 | 58,864 | Jan 21, 2020, 04:28 PM |
| Holloway Jean F | VP, General Counsel | Dec 12, 2019 | Option Exercise | $10.24 | 3,000 | 30,720 | 61,864 | Dec 13, 2019, 04:16 PM |
| Holloway Jean F | VP, General Counsel | Dec 12, 2019 | Sale | $26.00 | 3,000 | 78,000 | 58,864 | Dec 13, 2019, 04:16 PM |
| Capps Scott B | VP, Clinical Research | Nov 26, 2019 | Option Exercise | $6.12 | 10,000 | 61,200 | 151,079 | Nov 27, 2019, 04:13 PM |
| Capps Scott B | VP, Clinical Research | Nov 26, 2019 | Sale | $24.93 | 7,184 | 179,108 | 143,895 | Nov 27, 2019, 04:13 PM |
| McCall Ronald D | Director | Nov 19, 2019 | Sale | $24.64 | 4,000 | 98,565 | 132,599 | Nov 19, 2019, 04:43 PM |
| Mackin James P | President & CEO | Nov 13, 2019 | Buy | $23.47 | 5,000 | 117,355 | 225,731 | Nov 13, 2019, 04:14 PM |
| MORGAN HARVEY | Director | Nov 06, 2019 | Option Exercise | $23.06 | 2,319 | 53,476 | 44,783 | Nov 07, 2019, 04:32 PM |
| Horton Amy | VP, Chief Accounting Officer | Jun 05, 2019 | Option Exercise | $29.17 | 1,000 | 29,170 | 99,329 | Jun 06, 2019, 04:48 PM |
| Capps Scott B | VP, Clinical Research | May 31, 2019 | Sale | $28.55 | 2,000 | 57,100 | 141,079 | Jun 03, 2019, 04:31 PM |
| McCall Ronald D | Director | May 24, 2019 | Sale | $28.47 | 1,563 | 44,499 | 136,599 | May 29, 2019, 04:16 PM |
| McCall Ronald D | Director | May 23, 2019 | Sale | $28.00 | 1,000 | 28,000 | 138,162 | May 24, 2019, 04:18 PM |
| McCall Ronald D | Director | May 22, 2019 | Sale | $29.02 | 2,700 | 78,346 | 139,162 | May 24, 2019, 04:18 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | May 13, 2019 | Option Exercise | $29.88 | 90 | 2,689 | 275,565 | May 14, 2019, 08:34 PM |
| Mackin James P | President & CEO | May 03, 2019 | Sale | $31.31 | 50,000 | 1,565,690 | 220,731 | May 07, 2019, 04:53 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | May 03, 2019 | Option Exercise | $6.12 | 16,666 | 101,996 | 300,910 | May 07, 2019, 04:48 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | May 03, 2019 | Sale | $31.36 | 25,255 | 791,959 | 284,244 | May 07, 2019, 04:48 PM |
| Holloway Jean F | VP, General Counsel | May 06, 2019 | Option Exercise | $9.64 | 8,654 | 83,425 | 67,020 | May 07, 2019, 04:47 PM |
| Holloway Jean F | VP, General Counsel | May 06, 2019 | Sale | $32.00 | 8,654 | 276,928 | 58,366 | May 07, 2019, 04:47 PM |
| Holloway Jean F | VP, General Counsel | May 01, 2019 | Option Exercise | $10.24 | 10,000 | 102,400 | 68,366 | May 03, 2019, 07:29 PM |
| Holloway Jean F | VP, General Counsel | May 01, 2019 | Sale | $31.50 | 10,000 | 315,000 | 58,366 | May 03, 2019, 07:29 PM |
| Saurini Sherry M | VP, Quality | Mar 14, 2019 | Option Exercise | $29.82 | 466 | 13,896 | 25,084 | Mar 18, 2019, 05:02 PM |
| McDermid James M | SVP, CHRO | Mar 14, 2019 | Option Exercise | $29.82 | 745 | 22,216 | 30,806 | Mar 18, 2019, 05:01 PM |
| Maier Dennis B | Vice President, Operations | Mar 14, 2019 | Option Exercise | $29.82 | 452 | 13,479 | 14,583 | Mar 18, 2019, 04:59 PM |
| Mackin James P | President & CEO | Mar 14, 2019 | Option Exercise | $29.82 | 5,237 | 156,165 | 270,731 | Mar 18, 2019, 04:58 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Mar 14, 2019 | Option Exercise | $28.92 | 1,029 | 29,762 | 284,244 | Mar 18, 2019, 04:57 PM |
| Horton Amy | VP, Chief Accounting Officer | Mar 14, 2019 | Option Exercise | $28.92 | 584 | 16,891 | 100,329 | Mar 18, 2019, 04:55 PM |
| Holloway Jean F | VP, General Counsel | Mar 14, 2019 | Option Exercise | $28.92 | 897 | 25,944 | 58,366 | Mar 18, 2019, 04:54 PM |
| Davis John E | Senior VP, Global Sales | Mar 14, 2019 | Option Exercise | $28.92 | 748 | 21,635 | 53,957 | Mar 18, 2019, 04:52 PM |
| Capps Scott B | VP, Clinical Research | Mar 14, 2019 | Option Exercise | $28.92 | 468 | 13,536 | 143,079 | Mar 18, 2019, 04:51 PM |
| Bogenschuetz Thomas J | VP, EMEA & General Manager | Mar 14, 2019 | Option Exercise | $28.92 | 735 | 21,256 | 20,615 | Mar 18, 2019, 04:48 PM |
| Horton Amy | VP, Chief Accounting Officer | Mar 06, 2019 | Option Exercise | $6.12 | 6,666 | 40,796 | 103,713 | Mar 08, 2019, 06:10 PM |
| Horton Amy | VP, Chief Accounting Officer | Mar 06, 2019 | Sale | $29.15 | 6,666 | 194,299 | 97,047 | Mar 08, 2019, 06:10 PM |
| Saurini Sherry M | VP, Quality | Mar 02, 2019 | Option Exercise | $29.70 | 1,388 | 41,224 | 22,460 | Mar 07, 2019, 09:44 PM |
| Saurini Sherry M | VP, Quality | Mar 01, 2019 | Option Exercise | $29.70 | 778 | 23,107 | 23,848 | Mar 04, 2019, 08:26 AM |
| McDermid James M | SVP, CHRO | Mar 01, 2019 | Option Exercise | $29.70 | 501 | 14,880 | 22,102 | Mar 04, 2019, 08:22 AM |
| Mackin James P | President & CEO | Mar 01, 2019 | Option Exercise | $29.70 | 8,103 | 240,659 | 228,593 | Mar 04, 2019, 08:19 AM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Mar 01, 2019 | Option Exercise | $29.70 | 2,015 | 59,846 | 272,561 | Mar 04, 2019, 08:17 AM |
| Horton Amy | VP, Chief Accounting Officer | Mar 01, 2019 | Option Exercise | $29.70 | 1,133 | 33,650 | 93,952 | Mar 04, 2019, 08:13 AM |
| Holloway Jean F | VP, General Counsel | Mar 01, 2019 | Option Exercise | $29.70 | 1,506 | 44,728 | 48,371 | Mar 04, 2019, 08:08 AM |
| Davis John E | Senior VP, Global Sales | Mar 01, 2019 | Option Exercise | $29.70 | 1,485 | 44,105 | 44,805 | Mar 04, 2019, 08:05 AM |
| Capps Scott B | VP, Clinical Research | Mar 01, 2019 | Option Exercise | $29.70 | 1,087 | 32,284 | 137,642 | Mar 04, 2019, 08:03 AM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 22, 2019 | Option Exercise | $29.38 | 1,103 | 32,406 | 274,576 | Feb 25, 2019, 07:53 PM |
| McCall Ronald D | Director | Feb 21, 2019 | Sale | $29.26 | 6,200 | 181,390 | 137,699 | Feb 25, 2019, 07:52 PM |
| Holloway Jean F | VP, General Counsel | Feb 22, 2019 | Option Exercise | $29.38 | 882 | 25,913 | 49,877 | Feb 25, 2019, 07:51 PM |
| Saurini Sherry M | VP, Quality | Feb 19, 2019 | Option Exercise | $28.84 | 1,760 | 50,758 | 24,626 | Feb 21, 2019, 05:30 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 19, 2019 | Option Exercise | $28.84 | 2,368 | 68,293 | 95,085 | Feb 21, 2019, 05:29 PM |
| Capps Scott B | VP, Clinical Research | Feb 19, 2019 | Option Exercise | $28.84 | 2,358 | 68,005 | 138,729 | Feb 21, 2019, 05:28 PM |
| Davis John E | Senior VP, Global Sales | Feb 19, 2019 | Option Exercise | $28.84 | 2,941 | 84,818 | 46,290 | Feb 21, 2019, 05:27 PM |
| Holloway Jean F | VP, General Counsel | Feb 19, 2019 | Option Exercise | $28.84 | 2,933 | 84,588 | 50,759 | Feb 21, 2019, 05:26 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 19, 2019 | Option Exercise | $28.84 | 4,053 | 116,889 | 275,679 | Feb 21, 2019, 05:25 PM |
| Mackin James P | President & CEO | Feb 19, 2019 | Option Exercise | $28.84 | 6,602 | 190,402 | 236,696 | Feb 21, 2019, 05:24 PM |
| Davis John E | Senior VP, Global Sales | Sep 18, 2018 | Option Exercise | $9.64 | 3,333 | 32,130 | 52,564 | Sep 20, 2018, 05:02 PM |
| Davis John E | Senior VP, Global Sales | Sep 18, 2018 | Sale | $33.86 | 3,333 | 112,843 | 49,231 | Sep 20, 2018, 05:02 PM |
| Davis John E | Senior VP, Global Sales | Sep 10, 2018 | Option Exercise | $34.00 | 3,512 | 119,408 | 49,231 | Sep 12, 2018, 04:50 PM |
| Holloway Jean F | VP, General Counsel | Sep 10, 2018 | Option Exercise | $34.00 | 2,201 | 74,834 | 53,385 | Sep 12, 2018, 12:00 AM |
| RONALD C ELKINS | Director | Sep 05, 2018 | Sale | $34.53 | 5,000 | 172,672 | 64,843 | Sep 06, 2018, 04:21 PM |
| Capps Scott B | VP, Clinical Research | Aug 30, 2018 | Option Exercise | $5.67 | 8,332 | 47,242 | 147,419 | Sep 04, 2018, 06:59 PM |
| Capps Scott B | VP, Clinical Research | Aug 30, 2018 | Sale | $34.10 | 6,332 | 215,921 | 141,087 | Sep 04, 2018, 06:59 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Aug 15, 2018 | Option Exercise | $5.67 | 16,666 | 94,496 | 296,398 | Aug 16, 2018, 05:24 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Aug 15, 2018 | Sale | $31.92 | 16,666 | 531,994 | 279,732 | Aug 16, 2018, 05:24 PM |
| MORGAN HARVEY | Director | Aug 14, 2018 | Sale | $32.66 | 2,369 | 77,373 | 38,298 | Aug 15, 2018, 05:49 PM |
| MORGAN HARVEY | Director | Aug 14, 2018 | Sale | $32.66 | 2,443 | 79,776 | 42,939 | Aug 15, 2018, 05:49 PM |
| MORGAN HARVEY | Director | Aug 13, 2018 | Sale | $32.44 | 5,188 | 168,283 | 45,382 | Aug 15, 2018, 05:49 PM |
| Mackin James P | President & CEO | Aug 14, 2018 | Option Exercise | $10.24 | 37,077 | 379,668 | 314,975 | Aug 15, 2018, 05:48 PM |
| Mackin James P | President & CEO | Aug 13, 2018 | Option Exercise | $10.24 | 103,072 | 1,055,457 | 380,970 | Aug 15, 2018, 05:48 PM |
| Mackin James P | President & CEO | Aug 15, 2018 | Option Exercise | $10.24 | 9,851 | 100,874 | 287,749 | Aug 15, 2018, 05:48 PM |
| Mackin James P | President & CEO | Aug 14, 2018 | Sale | $32.22 | 37,077 | 1,194,473 | 277,898 | Aug 15, 2018, 05:48 PM |
| Mackin James P | President & CEO | Aug 13, 2018 | Sale | $32.17 | 103,072 | 3,315,950 | 277,898 | Aug 15, 2018, 05:48 PM |
| Mackin James P | President & CEO | Aug 15, 2018 | Sale | $31.79 | 9,851 | 313,209 | 277,898 | Aug 15, 2018, 05:48 PM |
| Mackin James P | President & CEO | Aug 10, 2018 | Sale | $33.32 | 42,675 | 1,421,968 | 297,050 | Aug 13, 2018, 04:43 PM |
| McCall Ronald D | Director | Aug 09, 2018 | Sale | $32.69 | 2,750 | 89,900 | 143,899 | Aug 13, 2018, 04:39 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Aug 10, 2018 | Sale | $32.98 | 10,247 | 337,924 | 279,732 | Aug 13, 2018, 04:37 PM |
| Horton Amy | VP, Chief Accounting Officer | Aug 10, 2018 | Sale | $32.85 | 3,000 | 98,550 | 97,453 | Aug 13, 2018, 04:35 PM |
| Holloway Jean F | VP, General Counsel | Aug 10, 2018 | Option Exercise | $10.28 | 1,500 | 15,420 | 60,235 | Aug 13, 2018, 04:34 PM |
| Holloway Jean F | VP, General Counsel | Aug 10, 2018 | Sale | $33.50 | 1,500 | 50,250 | 58,735 | Aug 13, 2018, 04:34 PM |
| RONALD C ELKINS | Director | Aug 10, 2018 | Sale | $33.27 | 1,154 | 38,393 | 69,843 | Aug 13, 2018, 04:31 PM |
| Holloway Jean F | VP, General Counsel | Aug 07, 2018 | Option Exercise | $10.28 | 4,000 | 41,120 | 62,735 | Aug 09, 2018, 05:27 PM |
| Holloway Jean F | VP, General Counsel | Aug 07, 2018 | Sale | $32.50 | 4,000 | 130,000 | 58,735 | Aug 09, 2018, 05:27 PM |
| Davis John E | Senior VP, Global Sales | Jul 26, 2018 | Option Exercise | $16.30 | 3,391 | 55,273 | 56,134 | Jul 30, 2018, 04:32 PM |
| Davis John E | Senior VP, Global Sales | Jul 26, 2018 | Sale | $31.00 | 3,391 | 105,121 | 52,743 | Jul 30, 2018, 04:32 PM |
| Holloway Jean F | VP, General Counsel | Jul 23, 2018 | Option Exercise | $10.28 | 1,500 | 15,420 | 60,235 | Jul 25, 2018, 04:44 PM |
| Holloway Jean F | VP, General Counsel | Jul 23, 2018 | Sale | $30.50 | 1,500 | 45,750 | 58,735 | Jul 25, 2018, 04:44 PM |
| Saurini Sherry M | VP, Quality | Jan 01, 2018 | Option Exercise | $16.24 | 191 | 3,101 | 26,274 | Jul 10, 2018, 04:49 PM |
| McDermid James M | SVP, CHRO | Jan 01, 2018 | Option Exercise | $16.24 | 1,179 | 19,141 | 22,518 | Jul 10, 2018, 04:47 PM |
| Holloway Jean F | VP, General Counsel | Jan 01, 2018 | Option Exercise | $16.24 | 861 | 13,978 | 58,738 | Jul 10, 2018, 04:46 PM |
| Davis John E | Senior VP, Global Sales | Jul 06, 2018 | Option Exercise | $16.30 | 3,391 | 55,273 | 56,137 | Jul 10, 2018, 04:43 PM |
| Davis John E | Senior VP, Global Sales | Jan 01, 2018 | Option Exercise | $16.24 | 1,308 | 21,235 | 52,746 | Jul 10, 2018, 04:43 PM |
| Davis John E | Senior VP, Global Sales | Jul 06, 2018 | Sale | $30.00 | 3,391 | 101,730 | 52,746 | Jul 10, 2018, 04:43 PM |
| Davis John E | Senior VP, Global Sales | Jun 14, 2018 | Option Exercise | $29.00 | 4,372 | 126,788 | 51,438 | Jun 15, 2018, 05:19 PM |
| Davis John E | Senior VP, Global Sales | Jun 14, 2018 | Option Exercise | $10.24 | 4,372 | 44,769 | 55,810 | Jun 15, 2018, 05:19 PM |
| RONALD C ELKINS | Director | Jun 14, 2018 | Sale | $28.89 | 5,000 | 144,446 | 70,997 | Jun 15, 2018, 05:17 PM |
| Horton Amy | VP, Chief Accounting Officer | Jun 01, 2018 | Option Exercise | $5.67 | 5,000 | 28,350 | 102,709 | Jun 05, 2018, 04:23 PM |
| Horton Amy | VP, Chief Accounting Officer | Jun 01, 2018 | Sale | $28.00 | 2,256 | 63,168 | 100,453 | Jun 05, 2018, 04:23 PM |
| Davis John E | Senior VP, Global Sales | Jun 01, 2018 | Option Exercise | $10.24 | 4,373 | 44,780 | 55,811 | Jun 05, 2018, 04:22 PM |
| Davis John E | Senior VP, Global Sales | Jun 01, 2018 | Sale | $28.00 | 4,373 | 122,444 | 51,438 | Jun 05, 2018, 04:22 PM |
| RONALD C ELKINS | Director | May 30, 2018 | Sale | $27.17 | 3,000 | 81,525 | 75,997 | Jun 01, 2018, 09:07 AM |
| Davis John E | Senior VP, Global Sales | May 16, 2018 | Option Exercise | $10.24 | 4,373 | 44,780 | 55,811 | May 18, 2018, 04:32 PM |
| Davis John E | Senior VP, Global Sales | May 16, 2018 | Sale | $27.00 | 4,373 | 118,071 | 51,438 | May 18, 2018, 04:32 PM |
| RONALD C ELKINS | Director | May 14, 2018 | Sale | $24.75 | 10,000 | 247,500 | 78,997 | May 15, 2018, 05:32 PM |
| McCall Ronald D | Director | May 08, 2018 | Sale | $25.95 | 260 | 6,747 | 142,011 | May 15, 2018, 05:30 PM |
| McCall Ronald D | Director | May 10, 2018 | Sale | $25.39 | 2,000 | 50,782 | 142,271 | May 11, 2018, 05:23 PM |
| McCall Ronald D | Director | May 09, 2018 | Sale | $25.67 | 2,240 | 57,494 | 144,271 | May 11, 2018, 05:23 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | May 10, 2018 | Option Exercise | $25.30 | 100 | 2,530 | 289,979 | May 11, 2018, 05:21 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | May 09, 2018 | Sale | $25.70 | 10,000 | 256,999 | 290,079 | May 11, 2018, 05:21 PM |
| Horton Amy | VP, Chief Accounting Officer | May 09, 2018 | Option Exercise | $25.45 | 1,250 | 31,813 | 97,709 | May 11, 2018, 05:20 PM |
| Horton Amy | VP, Chief Accounting Officer | May 09, 2018 | Sale | $25.94 | 4,000 | 103,764 | 98,959 | May 11, 2018, 05:20 PM |
| Davis John E | Senior VP, Global Sales | May 08, 2018 | Option Exercise | $10.24 | 4,373 | 44,780 | 55,811 | May 10, 2018, 04:43 PM |
| Davis John E | Senior VP, Global Sales | May 08, 2018 | Sale | $26.00 | 4,373 | 113,698 | 51,438 | May 10, 2018, 04:43 PM |
| RONALD C ELKINS | Director | May 10, 2018 | Sale | $25.30 | 5,000 | 126,500 | 88,997 | May 10, 2018, 04:41 PM |
| RONALD C ELKINS | Director | May 08, 2018 | Sale | $25.58 | 1,852 | 47,379 | 93,997 | May 10, 2018, 04:41 PM |
| RONALD C ELKINS | Director | May 03, 2018 | Sale | $24.00 | 2,000 | 48,000 | 95,849 | May 08, 2018, 04:26 PM |
| Davis John E | Senior VP, Global Sales | May 03, 2018 | Option Exercise | $9.64 | 3,334 | 32,140 | 54,772 | May 08, 2018, 04:24 PM |
| Davis John E | Senior VP, Global Sales | May 03, 2018 | Sale | $24.00 | 3,334 | 80,016 | 51,438 | May 08, 2018, 04:24 PM |
| Davis John E | Senior VP, Global Sales | Apr 17, 2018 | Option Exercise | $9.64 | 3,333 | 32,130 | 54,771 | Apr 18, 2018, 04:42 PM |
| Davis John E | Senior VP, Global Sales | Apr 17, 2018 | Sale | $23.00 | 3,333 | 76,659 | 51,438 | Apr 18, 2018, 04:42 PM |
| Holloway Jean F | VP, General Counsel | Apr 01, 2018 | Option Exercise | $20.05 | 2,125 | 42,606 | 57,877 | Apr 03, 2018, 08:58 AM |
| Matthews William Robert | Senior VP, Operations, Quality | Mar 05, 2018 | Option Exercise | $19.15 | 886 | 16,967 | 39,883 | Mar 26, 2018, 04:31 PM |
| McCall Ronald D | Director | Mar 08, 2018 | Sale | $21.09 | 5,000 | 105,448 | 146,511 | Mar 09, 2018, 04:51 PM |
| RONALD C ELKINS | Director | Mar 08, 2018 | Sale | $22.00 | 2,000 | 44,000 | 97,849 | Mar 09, 2018, 04:51 PM |
| Mackin James P | President & CEO | Mar 05, 2018 | Option Exercise | $19.15 | 6,349 | 121,583 | 320,933 | Mar 07, 2018, 05:26 PM |
| McDermid James M | SVP, CHRO | Mar 05, 2018 | Option Exercise | $19.15 | 997 | 19,093 | 15,152 | Mar 07, 2018, 05:26 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Mar 05, 2018 | Option Exercise | $19.15 | 1,245 | 23,842 | 291,572 | Mar 07, 2018, 05:26 PM |
| Horton Amy | VP, Chief Accounting Officer | Mar 05, 2018 | Option Exercise | $19.15 | 698 | 13,367 | 98,125 | Mar 07, 2018, 05:26 PM |
| Holloway Jean F | VP, General Counsel | Mar 05, 2018 | Option Exercise | $19.15 | 1,022 | 19,571 | 52,577 | Mar 07, 2018, 05:19 PM |
| Davis John E | Senior VP, Global Sales | Mar 05, 2018 | Option Exercise | $19.15 | 957 | 18,327 | 45,251 | Mar 07, 2018, 05:19 PM |
| Capps Scott B | VP, Clinical Research | Mar 05, 2018 | Option Exercise | $19.15 | 607 | 11,624 | 135,220 | Mar 07, 2018, 05:19 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 19, 2018 | Option Exercise | $18.25 | 3,744 | 68,328 | 284,617 | Feb 21, 2018, 07:50 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 19, 2018 | Option Exercise | $18.25 | 1,480 | 27,010 | 94,223 | Feb 21, 2018, 07:46 PM |
| Capps Scott B | VP, Clinical Research | Feb 19, 2018 | Option Exercise | $18.25 | 2,246 | 40,990 | 131,827 | Feb 21, 2018, 07:44 PM |
| Mackin James P | President & CEO | Feb 19, 2018 | Option Exercise | $18.25 | 9,527 | 173,868 | 299,282 | Feb 21, 2018, 07:44 PM |
| Matthews William Robert | Senior VP, Operations, Quality | Feb 19, 2018 | Option Exercise | $18.25 | 1,183 | 21,590 | 35,117 | Feb 21, 2018, 05:26 PM |
| Mackin James P | President & CEO | Feb 19, 2018 | Option Exercise | $18.25 | 7,640 | 139,430 | 313,400 | Feb 21, 2018, 05:23 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 19, 2018 | Option Exercise | $18.25 | 2,788 | 50,881 | 289,774 | Feb 21, 2018, 05:23 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 19, 2018 | Option Exercise | $18.25 | 1,502 | 27,412 | 96,636 | Feb 21, 2018, 05:20 PM |
| Holloway Jean F | VP, General Counsel | Feb 19, 2018 | Option Exercise | $18.25 | 1,877 | 34,255 | 47,858 | Feb 21, 2018, 05:18 PM |
| Davis John E | Senior VP, Global Sales | Feb 19, 2018 | Option Exercise | $18.25 | 1,183 | 21,590 | 39,708 | Feb 21, 2018, 05:16 PM |
| Capps Scott B | VP, Clinical Research | Feb 19, 2018 | Option Exercise | $18.25 | 1,521 | 27,758 | 134,868 | Feb 21, 2018, 05:15 PM |
| Capps Scott B | VP, Clinical Research | Feb 13, 2018 | Option Exercise | $17.10 | 9,381 | 160,415 | 104,261 | Feb 15, 2018, 05:28 PM |
| Capps Scott B | VP, Clinical Research | Feb 13, 2018 | Option Exercise | $5.12 | 31,333 | 160,425 | 135,594 | Feb 15, 2018, 05:28 PM |
| RONALD C ELKINS | Director | Dec 15, 2017 | Sale | $20.00 | 1,000 | 20,000 | 99,849 | Dec 19, 2017, 05:30 PM |
| Gale David C | VP, Research & Development | Nov 16, 2017 | Option Exercise | $5.94 | 20,000 | 118,800 | 87,135 | Nov 17, 2017, 04:17 PM |
| Gale David C | VP, Research & Development | Nov 16, 2017 | Sale | $19.63 | 20,000 | 392,500 | 77,135 | Nov 17, 2017, 04:17 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Nov 09, 2017 | Option Exercise | $5.12 | 30,143 | 154,332 | 321,292 | Nov 13, 2017, 04:47 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Nov 08, 2017 | Option Exercise | $5.12 | 33,190 | 169,933 | 324,339 | Nov 13, 2017, 04:47 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Nov 08, 2017 | Sale | $19.00 | 33,190 | 630,550 | 291,149 | Nov 13, 2017, 04:47 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Nov 09, 2017 | Sale | $18.57 | 30,143 | 559,888 | 291,149 | Nov 13, 2017, 04:47 PM |
| Horton Amy | VP, Chief Accounting Officer | Nov 08, 2017 | Sale | $19.00 | 4,000 | 76,000 | 98,705 | Nov 13, 2017, 04:45 PM |
| RONALD C ELKINS | Director | Nov 06, 2017 | Sale | $19.03 | 1,000 | 19,030 | 100,849 | Nov 08, 2017, 05:22 PM |
| Benson James | Director | Oct 02, 2017 | Sale | $22.80 | 2,000 | 45,600 | 54,086 | Oct 04, 2017, 04:49 PM |
| Mackin James P | President & CEO | Sep 06, 2017 | Sale | $21.97 | 81,950 | 1,800,679 | 316,449 | Sep 06, 2017, 05:43 PM |
| Mackin James P | President & CEO | Sep 05, 2017 | Sale | $22.09 | 43,050 | 951,061 | 398,399 | Sep 06, 2017, 05:43 PM |
| RONALD C ELKINS | Director | Sep 05, 2017 | Sale | $22.00 | 1,000 | 22,000 | 101,849 | Sep 06, 2017, 05:42 PM |
| Benson James | Director | Jul 03, 2017 | Option Exercise | $19.95 | 2,000 | 39,900 | 56,086 | Jul 06, 2017, 05:03 PM |
| Horton Amy | VP, Chief Accounting Officer | Jun 27, 2017 | Option Exercise | $5.12 | 18,667 | 95,575 | 112,282 | Jun 29, 2017, 09:19 AM |
| Horton Amy | VP, Chief Accounting Officer | Jun 27, 2017 | Sale | $20.00 | 9,577 | 191,540 | 102,705 | Jun 29, 2017, 09:19 AM |
| McCall Ronald D | Director | May 22, 2017 | Option Exercise | $18.28 | 7,000 | 127,938 | 151,511 | May 24, 2017, 09:21 AM |
| Benson James | Director | Apr 03, 2017 | Option Exercise | $16.60 | 2,000 | 33,200 | 58,086 | Apr 10, 2017, 04:57 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 26, 2017 | Option Exercise | $17.25 | 278 | 4,796 | 93,615 | Feb 28, 2017, 05:33 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 26, 2017 | Option Exercise | $17.25 | 2,224 | 38,364 | 93,893 | Feb 28, 2017, 05:33 PM |
| Gale David C | VP, Research & Development | Feb 26, 2017 | Option Exercise | $17.25 | 3,752 | 64,722 | 77,552 | Feb 28, 2017, 05:31 PM |
| Capps Scott B | VP, Clinical Research | Feb 26, 2017 | Option Exercise | $17.25 | 3,752 | 64,722 | 114,059 | Feb 28, 2017, 05:28 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 26, 2017 | Option Exercise | $17.25 | 6,254 | 107,882 | 291,884 | Feb 28, 2017, 05:27 PM |
| Capps Scott B | VP, Clinical Research | Feb 22, 2017 | Option Exercise | $7.01 | 16,667 | 116,836 | 128,477 | Feb 24, 2017, 09:10 AM |
| Capps Scott B | VP, Clinical Research | Feb 22, 2017 | Sale | $16.40 | 11,083 | 181,776 | 117,394 | Feb 24, 2017, 09:10 AM |
| Matthews William Robert | Senior VP, Operations, Quality | Feb 19, 2017 | Option Exercise | $17.25 | 13,262 | 228,770 | 32,232 | Feb 22, 2017, 07:00 PM |
| Matthews William Robert | Senior VP, Operations, Quality | Feb 19, 2017 | Option Exercise | $17.25 | 2,212 | 38,157 | 30,020 | Feb 22, 2017, 07:00 PM |
| Mackin James P | President & CEO | Feb 19, 2017 | Option Exercise | $17.25 | 60,496 | 1,043,556 | 425,705 | Feb 22, 2017, 06:58 PM |
| Mackin James P | President & CEO | Feb 19, 2017 | Option Exercise | $17.25 | 16,691 | 287,920 | 412,338 | Feb 22, 2017, 06:58 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 19, 2017 | Option Exercise | $17.25 | 18,614 | 321,092 | 291,396 | Feb 22, 2017, 06:55 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 19, 2017 | Option Exercise | $17.25 | 4,434 | 76,487 | 288,292 | Feb 22, 2017, 06:55 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 19, 2017 | Option Exercise | $17.25 | 10,471 | 180,625 | 92,751 | Feb 22, 2017, 06:53 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 19, 2017 | Option Exercise | $17.25 | 2,263 | 39,037 | 91,006 | Feb 22, 2017, 06:53 PM |
| Holloway Jean F | VP, General Counsel | Feb 19, 2017 | Option Exercise | $17.25 | 13,262 | 228,770 | 46,829 | Feb 22, 2017, 06:50 PM |
| Holloway Jean F | VP, General Counsel | Feb 19, 2017 | Option Exercise | $17.25 | 2,996 | 51,681 | 44,617 | Feb 22, 2017, 06:50 PM |
| Gale David C | VP, Research & Development | Feb 19, 2017 | Option Exercise | $17.25 | 10,471 | 180,625 | 78,854 | Feb 22, 2017, 06:39 PM |
| Gale David C | VP, Research & Development | Feb 19, 2017 | Option Exercise | $17.25 | 2,522 | 43,505 | 77,109 | Feb 22, 2017, 06:39 PM |
| Davis John E | Senior VP, Global Sales | Feb 19, 2017 | Option Exercise | $17.25 | 13,262 | 228,770 | 32,576 | Feb 22, 2017, 06:36 PM |
| Davis John E | Senior VP, Global Sales | Feb 19, 2017 | Option Exercise | $17.25 | 2,212 | 38,157 | 30,364 | Feb 22, 2017, 06:36 PM |
| Capps Scott B | VP, Clinical Research | Feb 19, 2017 | Option Exercise | $17.25 | 10,471 | 180,625 | 109,113 | Feb 22, 2017, 06:33 PM |
| Capps Scott B | VP, Clinical Research | Feb 19, 2017 | Option Exercise | $17.25 | 2,532 | 43,677 | 107,366 | Feb 22, 2017, 06:33 PM |
| Benson James | Director | Jan 03, 2017 | Option Exercise | $19.10 | 2,000 | 38,200 | 60,086 | Jan 05, 2017, 04:58 PM |
| RONALD C ELKINS | Director | Nov 23, 2016 | Option Exercise | $20.00 | 2,000 | 40,000 | 97,586 | Nov 28, 2016, 04:45 PM |
| RONALD C ELKINS | Director | Nov 14, 2016 | Option Exercise | $18.65 | 2,000 | 37,302 | 99,586 | Nov 16, 2016, 04:48 PM |
| Benson James | Director | Oct 31, 2016 | Option Exercise | $16.75 | 2,000 | 33,501 | 62,086 | Nov 01, 2016, 04:32 PM |
| RONALD C ELKINS | Director | Sep 20, 2016 | Option Exercise | $18.00 | 1,000 | 18,000 | 101,586 | Sep 22, 2016, 05:00 PM |
| McCall Ronald D | Director | Sep 15, 2016 | Option Exercise | $17.54 | 3,000 | 52,631 | 153,248 | Sep 16, 2016, 04:31 PM |
| Matthews William Robert | Senior VP, Operations, Quality | Sep 13, 2016 | Option Exercise | $17.39 | 1,156 | 20,100 | 18,970 | Sep 15, 2016, 05:00 PM |
| Holloway Jean F | VP, General Counsel | Sep 12, 2016 | Option Exercise | $17.03 | 3,000 | 51,081 | 34,351 | Sep 14, 2016, 05:30 PM |
| Holloway Jean F | VP, General Counsel | Sep 12, 2016 | Option Exercise | $9.64 | 3,000 | 28,920 | 37,351 | Sep 14, 2016, 05:30 PM |
| Gale David C | VP, Research & Development | Sep 12, 2016 | Option Exercise | $17.49 | 3,000 | 52,459 | 71,190 | Sep 14, 2016, 05:21 PM |
| Gale David C | VP, Research & Development | Sep 12, 2016 | Option Exercise | $7.01 | 3,000 | 21,030 | 74,190 | Sep 14, 2016, 05:21 PM |
| RONALD C ELKINS | Director | Sep 12, 2016 | Option Exercise | $17.25 | 1,000 | 17,249 | 102,586 | Sep 14, 2016, 05:19 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Sep 09, 2016 | Option Exercise | $17.26 | 28,847 | 498,035 | 272,612 | Sep 13, 2016, 06:07 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Sep 12, 2016 | Option Exercise | $17.29 | 2,986 | 51,629 | 272,612 | Sep 13, 2016, 06:07 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Sep 12, 2016 | Option Exercise | $7.01 | 4,486 | 31,447 | 275,598 | Sep 13, 2016, 06:07 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Sep 09, 2016 | Option Exercise | $7.01 | 28,847 | 202,217 | 301,459 | Sep 13, 2016, 06:07 PM |
| Horton Amy | VP, Chief Accounting Officer | Sep 09, 2016 | Option Exercise | $17.53 | 2,000 | 35,057 | 86,548 | Sep 13, 2016, 06:06 PM |
| Horton Amy | VP, Chief Accounting Officer | Sep 13, 2016 | Option Exercise | $17.47 | 3,000 | 52,410 | 82,798 | Sep 13, 2016, 06:06 PM |
| Benson James | Director | Sep 09, 2016 | Option Exercise | $17.18 | 10,000 | 171,800 | 64,086 | Sep 13, 2016, 06:04 PM |
| Horton Amy | VP, Chief Accounting Officer | Jul 26, 2016 | Option Exercise | $14.00 | 6,774 | 94,836 | 88,548 | Jul 28, 2016, 04:34 PM |
| Horton Amy | VP, Chief Accounting Officer | Jul 26, 2016 | Option Exercise | $7.01 | 10,000 | 70,100 | 95,322 | Jul 28, 2016, 04:34 PM |
| RONALD C ELKINS | Director | Jul 26, 2016 | Sale | $14.00 | 2,000 | 28,000 | 103,586 | Jul 28, 2016, 04:31 PM |
| McCall Ronald D | Director | Jun 01, 2016 | Sale | $11.56 | 10,000 | 115,600 | 156,248 | Jun 03, 2016, 07:03 AM |
| Benson James | Director | May 10, 2016 | Sale | $12.22 | 5,000 | 61,100 | 65,352 | May 12, 2016, 04:31 PM |
| RONALD C ELKINS | Director | Apr 15, 2016 | Sale | $12.00 | 1,000 | 12,000 | 96,852 | Apr 19, 2016, 04:29 PM |
| RONALD C ELKINS | Director | Mar 07, 2016 | Sale | $11.18 | 2,000 | 22,360 | 97,852 | Mar 09, 2016, 08:10 AM |
| Mackin James P | President & CEO | Mar 04, 2016 | Buy | $10.94 | 4,600 | 50,324 | 368,533 | Mar 04, 2016, 05:20 PM |
| Mackin James P | President & CEO | Mar 03, 2016 | Buy | $10.89 | 5,400 | 58,806 | 363,933 | Mar 04, 2016, 05:20 PM |
| Gale David C | VP, Research & Development | Feb 26, 2016 | Option Exercise | $10.54 | 416 | 4,385 | 71,606 | Mar 01, 2016, 04:41 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 26, 2016 | Option Exercise | $10.54 | 694 | 7,315 | 272,612 | Mar 01, 2016, 04:39 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 26, 2016 | Option Exercise | $10.54 | 277 | 2,920 | 85,322 | Mar 01, 2016, 04:37 PM |
| Capps Scott B | VP, Clinical Research | Feb 26, 2016 | Option Exercise | $10.54 | 416 | 4,385 | 99,427 | Mar 01, 2016, 04:34 PM |
| Gale David C | VP, Research & Development | Nov 08, 2013 | Option Exercise | $9.90 | 100 | 990 | 36,199 | Mar 01, 2016, 04:33 PM |
| Gale David C | VP, Research & Development | Nov 11, 2013 | Sale | $9.97 | 150 | 1,496 | 36,049 | Mar 01, 2016, 04:33 PM |
| Saurini Sherry M | VP, Quality | Feb 19, 2016 | Option Exercise | $10.24 | 5,294 | 54,211 | 5,294 | Feb 23, 2016, 05:47 PM |
| Matthews William Robert | Senior VP, Operations, Quality | Feb 19, 2016 | Option Exercise | $10.24 | 9,314 | 95,375 | 17,814 | Feb 23, 2016, 05:45 PM |
| Mackin James P | President & CEO | Feb 19, 2016 | Option Exercise | $10.24 | 42,484 | 435,036 | 325,316 | Feb 23, 2016, 05:44 PM |
| Mackin James P | President & CEO | Feb 19, 2016 | Option Exercise | $10.24 | 6,647 | 68,065 | 358,533 | Feb 23, 2016, 05:44 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 19, 2016 | Option Exercise | $10.24 | 13,072 | 133,857 | 256,356 | Feb 23, 2016, 05:43 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 22, 2016 | Option Exercise | $10.48 | 3,662 | 38,378 | 273,306 | Feb 23, 2016, 05:43 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 19, 2016 | Option Exercise | $10.24 | 2,658 | 27,218 | 269,644 | Feb 23, 2016, 05:43 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 19, 2016 | Option Exercise | $10.24 | 7,353 | 75,295 | 80,284 | Feb 23, 2016, 05:41 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 19, 2016 | Option Exercise | $10.24 | 1,063 | 10,885 | 85,599 | Feb 23, 2016, 05:41 PM |
| Holloway Jean F | VP, General Counsel | Feb 22, 2016 | Option Exercise | $10.48 | 2,930 | 30,706 | 34,351 | Feb 23, 2016, 05:39 PM |
| Holloway Jean F | VP, General Counsel | Feb 19, 2016 | Option Exercise | $10.24 | 9,314 | 95,375 | 23,566 | Feb 23, 2016, 05:39 PM |
| Holloway Jean F | VP, General Counsel | Feb 19, 2016 | Option Exercise | $10.24 | 1,521 | 15,575 | 31,421 | Feb 23, 2016, 05:39 PM |
| Gale David C | VP, Research & Development | Feb 19, 2016 | Option Exercise | $10.24 | 7,353 | 75,295 | 61,605 | Feb 23, 2016, 05:37 PM |
| Gale David C | VP, Research & Development | Feb 19, 2016 | Option Exercise | $10.24 | 1,594 | 16,323 | 69,575 | Feb 23, 2016, 05:37 PM |
| Davis John E | Senior VP, Global Sales | Feb 19, 2016 | Option Exercise | $10.24 | 9,314 | 95,375 | 19,314 | Feb 23, 2016, 05:36 PM |
| Capps Scott B | VP, Clinical Research | Feb 19, 2016 | Option Exercise | $10.24 | 7,353 | 75,295 | 91,873 | Feb 23, 2016, 05:35 PM |
| Capps Scott B | VP, Clinical Research | Feb 19, 2016 | Option Exercise | $10.24 | 1,594 | 16,323 | 99,843 | Feb 23, 2016, 05:35 PM |
| Capps Scott B | VP, Clinical Research | Feb 19, 2016 | Option Exercise | $4.83 | 15,000 | 72,450 | 106,455 | Feb 23, 2016, 05:35 PM |
| Capps Scott B | VP, Clinical Research | Feb 19, 2016 | Sale | $10.30 | 15,000 | 154,500 | 91,873 | Feb 23, 2016, 05:35 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 17, 2016 | Option Exercise | $10.20 | 4,261 | 43,462 | 72,931 | Feb 19, 2016, 04:36 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 17, 2016 | Option Exercise | $4.83 | 9,000 | 43,470 | 77,192 | Feb 19, 2016, 04:36 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 17, 2016 | Option Exercise | $10.20 | 6,012 | 61,322 | 243,284 | Feb 19, 2016, 04:35 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 18, 2016 | Option Exercise | $4.83 | 8,000 | 38,640 | 251,284 | Feb 19, 2016, 04:35 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 17, 2016 | Option Exercise | $4.83 | 12,700 | 61,341 | 247,166 | Feb 19, 2016, 04:35 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 18, 2016 | Sale | $10.13 | 8,000 | 81,040 | 243,284 | Feb 19, 2016, 04:35 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 15, 2016 | Option Exercise | $9.06 | 5,558 | 50,355 | 236,296 | Feb 16, 2016, 04:38 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 12, 2016 | Option Exercise | $9.06 | 1,615 | 14,632 | 241,854 | Feb 16, 2016, 04:38 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 15, 2016 | Option Exercise | $9.06 | 2,223 | 20,140 | 68,192 | Feb 16, 2016, 04:36 PM |
| Horton Amy | VP, Chief Accounting Officer | Feb 12, 2016 | Option Exercise | $9.06 | 645 | 5,844 | 70,415 | Feb 16, 2016, 04:36 PM |
| Capps Scott B | VP, Clinical Research | Feb 15, 2016 | Option Exercise | $9.06 | 3,290 | 29,807 | 84,520 | Feb 16, 2016, 04:35 PM |
| Capps Scott B | VP, Clinical Research | Feb 12, 2016 | Option Exercise | $9.06 | 942 | 8,535 | 87,810 | Feb 16, 2016, 04:35 PM |
| Gale David C | VP, Research & Development | Feb 15, 2016 | Option Exercise | $9.06 | 3,283 | 29,744 | 54,252 | Feb 16, 2016, 04:33 PM |
| Gale David C | VP, Research & Development | Feb 12, 2016 | Option Exercise | $9.06 | 942 | 8,535 | 57,535 | Feb 16, 2016, 04:33 PM |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | Dec 28, 2015 | Option Exercise | $4.83 | 1,000 | 4,830 | 244,669 | Dec 30, 2015, 03:25 PM |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | Dec 28, 2015 | Sale | $11.00 | 700 | 7,700 | 243,969 | Dec 30, 2015, 03:25 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Nov 27, 2015 | Option Exercise | $4.83 | 10,581 | 51,106 | 250,550 | Dec 01, 2015, 04:35 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Nov 30, 2015 | Option Exercise | $4.83 | 5,219 | 25,208 | 243,969 | Dec 01, 2015, 04:35 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Nov 30, 2015 | Sale | $11.02 | 1,219 | 13,439 | 239,969 | Dec 01, 2015, 04:35 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Nov 27, 2015 | Sale | $11.03 | 10,581 | 116,708 | 239,969 | Dec 01, 2015, 04:35 PM |
| Benson James | Director | Sep 15, 2015 | Sale | $9.65 | 5,839 | 56,346 | 70,352 | Sep 17, 2015, 08:32 AM |
| Benson James | Director | Sep 11, 2015 | Sale | $9.65 | 4,161 | 40,154 | 76,191 | Sep 15, 2015, 04:34 PM |
| Benson James | Director | Sep 11, 2015 | Sale | $9.65 | 3,359 | 32,414 | 76,993 | Sep 14, 2015, 04:41 PM |
| ANDERSON STEVEN G | Former Executive Chairman | Apr 09, 2015 | Option Exercise | $10.18 | 44,404 | 452,033 | 1,271,846 | Apr 15, 2015, 05:01 PM |
| ANDERSON STEVEN G | Former Executive Chairman | Apr 09, 2015 | Option Exercise | $10.18 | 57,681 | 587,193 | 1,258,569 | Apr 13, 2015, 05:30 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Mar 07, 2015 | Option Exercise | $10.51 | 1,739 | 18,277 | 239,719 | Mar 10, 2015, 04:54 PM |
| Horton Amy | Chief Accounting Officer | Mar 07, 2015 | Option Exercise | $10.51 | 507 | 5,329 | 71,060 | Mar 10, 2015, 04:53 PM |
| Gale David C | VP, Research & Development | Mar 07, 2015 | Option Exercise | $10.51 | 1,043 | 10,962 | 58,477 | Mar 10, 2015, 04:47 PM |
| FRONK DAVID | VP, Regulatory Affairs | Mar 07, 2015 | Option Exercise | $10.51 | 1,217 | 12,791 | 110,559 | Mar 10, 2015, 04:45 PM |
| Capps Scott B | VP, Clinical Research | Mar 07, 2015 | Option Exercise | $10.51 | 869 | 9,133 | 88,752 | Mar 10, 2015, 04:44 PM |
| ANDERSON STEVEN G | Executive Chairman | Mar 07, 2015 | Option Exercise | $10.51 | 5,469 | 57,479 | 1,316,250 | Mar 10, 2015, 04:43 PM |
| Anderson Bruce G. | VP, US Sales &Global Marketing | Mar 07, 2015 | Option Exercise | $10.51 | 695 | 7,304 | 42,106 | Mar 10, 2015, 04:41 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 26, 2015 | Option Exercise | $10.72 | 1,389 | 14,890 | 241,458 | Feb 27, 2015, 05:00 PM |
| Capps Scott B | VP, Clinical Research | Feb 26, 2015 | Option Exercise | $10.72 | 833 | 8,930 | 89,621 | Feb 27, 2015, 04:58 PM |
| ANDERSON STEVEN G | Executive Chairman | Feb 26, 2015 | Option Exercise | $10.72 | 4,298 | 46,075 | 1,321,719 | Feb 27, 2015, 04:56 PM |
| FRONK DAVID | VP, Regulatory Affairs | Feb 26, 2015 | Option Exercise | $10.72 | 972 | 10,420 | 111,776 | Feb 27, 2015, 04:55 PM |
| Horton Amy | Chief Accounting Officer | Feb 26, 2015 | Option Exercise | $10.72 | 540 | 5,789 | 71,567 | Feb 27, 2015, 04:53 PM |
| Gale David C | VP, Research & Development | Feb 26, 2015 | Option Exercise | $10.72 | 833 | 8,930 | 59,520 | Feb 27, 2015, 04:51 PM |
| Anderson Bruce G. | VP, US Sales &Global Marketing | Feb 26, 2015 | Option Exercise | $10.72 | 833 | 8,930 | 42,801 | Feb 27, 2015, 04:47 PM |
| ANDERSON STEVEN G | Executive Chairman | Feb 23, 2015 | Option Exercise | $10.47 | 59,243 | 620,274 | 1,305,183 | Feb 25, 2015, 08:36 AM |
| ANDERSON STEVEN G | Executive Chairman | Feb 23, 2015 | Option Exercise | $9.73 | 63,750 | 620,287 | 1,364,426 | Feb 25, 2015, 08:36 AM |
| FRONK DAVID | VP, Regulatory Affairs | Feb 16, 2015 | Option Exercise | $11.30 | 12,915 | 145,940 | 106,914 | Feb 25, 2015, 08:33 AM |
| FRONK DAVID | VP, Regulatory Affairs | Feb 16, 2015 | Option Exercise | $9.73 | 15,000 | 145,950 | 119,829 | Feb 25, 2015, 08:33 AM |
| Mackin James P | President & CEO | Feb 19, 2015 | Option Exercise | $11.00 | 30,832 | 339,152 | 280,832 | Feb 20, 2015, 04:55 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 19, 2015 | Option Exercise | $11.00 | 12,333 | 135,663 | 234,513 | Feb 20, 2015, 04:53 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 18, 2015 | Option Exercise | $10.82 | 5,558 | 60,138 | 222,180 | Feb 20, 2015, 04:53 PM |
| Lang David P. | VP, Int'l Sales & Marketing | Feb 19, 2015 | Option Exercise | $11.00 | 7,399 | 81,389 | 68,441 | Feb 20, 2015, 04:52 PM |
| Horton Amy | Chief Accounting Officer | Feb 19, 2015 | Option Exercise | $11.00 | 4,933 | 54,263 | 68,773 | Feb 20, 2015, 04:50 PM |
| Horton Amy | Chief Accounting Officer | Feb 18, 2015 | Option Exercise | $10.82 | 1,852 | 20,039 | 63,840 | Feb 20, 2015, 04:50 PM |
| Gale David C | VP, Research & Development | Feb 19, 2015 | Option Exercise | $11.00 | 7,399 | 81,389 | 55,353 | Feb 20, 2015, 04:49 PM |
| Gale David C | VP, Research & Development | Feb 18, 2015 | Option Exercise | $10.82 | 3,417 | 36,972 | 47,954 | Feb 20, 2015, 04:49 PM |
| FRONK DAVID | VP, Regulatory Affairs | Feb 19, 2015 | Option Exercise | $11.00 | 8,633 | 94,963 | 104,829 | Feb 20, 2015, 04:47 PM |
| FRONK DAVID | VP, Regulatory Affairs | Feb 18, 2015 | Option Exercise | $10.82 | 4,022 | 43,518 | 96,196 | Feb 20, 2015, 04:47 PM |
| Capps Scott B | VP, Clinical Research | Feb 19, 2015 | Option Exercise | $11.00 | 7,399 | 81,389 | 85,454 | Feb 20, 2015, 04:46 PM |
| Capps Scott B | VP, Clinical Research | Feb 18, 2015 | Option Exercise | $10.82 | 2,793 | 30,220 | 78,055 | Feb 20, 2015, 04:46 PM |
| ANDERSON STEVEN G | Executive Chairman | Feb 18, 2015 | Option Exercise | $10.82 | 11,395 | 123,294 | 1,330,676 | Feb 20, 2015, 04:45 PM |
| ANDERSON STEVEN G | Executive Chairman | Feb 19, 2015 | Sale | $10.93 | 30,000 | 327,945 | 1,300,676 | Feb 20, 2015, 04:45 PM |
| Anderson Bruce G. | VP, US Sales &Global Marketing | Feb 19, 2015 | Option Exercise | $11.00 | 7,399 | 81,389 | 38,634 | Feb 20, 2015, 04:43 PM |
| Anderson Bruce G. | VP, US Sales &Global Marketing | Feb 18, 2015 | Option Exercise | $10.82 | 2,207 | 23,880 | 31,235 | Feb 20, 2015, 04:43 PM |
| Horton Amy | Chief Accounting Officer | Feb 12, 2015 | Option Exercise | $11.40 | 748 | 8,527 | 65,692 | Feb 13, 2015, 05:25 PM |
| ANDERSON STEVEN G | Chairman | Feb 12, 2015 | Option Exercise | $11.40 | 4,262 | 48,587 | 1,342,071 | Feb 13, 2015, 05:04 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Feb 12, 2015 | Option Exercise | $11.40 | 1,871 | 21,329 | 227,738 | Feb 13, 2015, 05:02 PM |
| Anderson Bruce G. | VP, US Sales &Global Marketing | Feb 12, 2015 | Option Exercise | $11.40 | 1,122 | 12,791 | 33,442 | Feb 13, 2015, 04:58 PM |
| FRONK DAVID | VP, Regulatory Affairs | Feb 12, 2015 | Option Exercise | $11.40 | 1,310 | 14,934 | 100,218 | Feb 13, 2015, 04:56 PM |
| Gale David C | VP, Research & Development | Feb 12, 2015 | Option Exercise | $11.40 | 1,122 | 12,791 | 51,371 | Feb 13, 2015, 04:53 PM |
| Capps Scott B | VP, Clinical Research | Feb 12, 2015 | Option Exercise | $11.40 | 1,122 | 12,791 | 80,848 | Feb 13, 2015, 04:50 PM |
| Anderson Bruce G. | VP, US Sales &Global Marketing | Dec 09, 2014 | Option Exercise | $9.10 | 3,900 | 35,499 | 37,564 | Dec 10, 2014, 04:50 PM |
| Anderson Bruce G. | VP, US Sales &Global Marketing | Dec 09, 2014 | Sale | $10.29 | 3,900 | 40,142 | 34,564 | Dec 10, 2014, 04:50 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Dec 04, 2014 | Option Exercise | $10.52 | 26,500 | 278,899 | 229,609 | Dec 05, 2014, 04:59 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Dec 04, 2014 | Option Exercise | $9.73 | 27,500 | 267,575 | 256,109 | Dec 05, 2014, 04:59 PM |
| Horton Amy | Chief Accounting Officer | Dec 02, 2014 | Option Exercise | $10.69 | 8,191 | 87,562 | 66,440 | Dec 04, 2014, 04:47 PM |
| Horton Amy | Chief Accounting Officer | Dec 02, 2014 | Option Exercise | $9.73 | 9,000 | 87,570 | 74,631 | Dec 04, 2014, 04:47 PM |
| Anderson Bruce G. | VP, US Sales &Global Marketing | Nov 25, 2014 | Option Exercise | $6.57 | 20,211 | 132,757 | 46,997 | Nov 26, 2014, 04:35 PM |
| Anderson Bruce G. | VP, US Sales &Global Marketing | Nov 25, 2014 | Sale | $10.11 | 20,211 | 204,368 | 34,564 | Nov 26, 2014, 04:35 PM |
| Gale David C | VP, Research & Development | Nov 08, 2014 | Option Exercise | $10.06 | 150 | 1,509 | 52,493 | Nov 12, 2014, 08:36 AM |
| RONALD C ELKINS | Director | Nov 05, 2014 | Sale | $10.08 | 4,000 | 40,320 | 89,500 | Nov 06, 2014, 04:53 PM |
| Benson James | Director | Nov 03, 2014 | Sale | $10.22 | 10,000 | 102,200 | 70,000 | Nov 04, 2014, 04:45 PM |
| Anderson Bruce G. | VP, US Sales &Global Marketing | Oct 30, 2014 | Option Exercise | $5.12 | 10,333 | 52,905 | 44,897 | Nov 03, 2014, 04:52 PM |
| Anderson Bruce G. | VP, US Sales &Global Marketing | Oct 30, 2014 | Sale | $10.09 | 10,333 | 104,247 | 34,564 | Nov 03, 2014, 04:52 PM |
| Anderson Bruce G. | VP, US Sales and Marketing | Sep 08, 2014 | Option Exercise | $5.12 | 10,000 | 51,200 | 44,564 | Sep 09, 2014, 04:59 PM |
| Anderson Bruce G. | VP, US Sales and Marketing | Sep 08, 2014 | Sale | $10.05 | 10,000 | 100,529 | 34,564 | Sep 09, 2014, 04:59 PM |
| ANDERSON STEVEN G | Chairman | Sep 02, 2014 | Sale | $10.08 | 20,000 | 201,502 | 1,346,333 | Sep 03, 2014, 04:54 PM |
| Anderson Bruce G. | VP, US Sales and Marketing | Aug 25, 2014 | Option Exercise | $5.12 | 5,000 | 25,600 | 39,564 | Aug 26, 2014, 05:01 PM |
| Anderson Bruce G. | VP, US Sales and Marketing | Aug 25, 2014 | Sale | $10.05 | 5,000 | 50,255 | 39,393 | Aug 26, 2014, 05:01 PM |
| Anderson Bruce G. | VP, US Sales and Marketing | Aug 18, 2014 | Option Exercise | $4.83 | 10,000 | 48,300 | 44,564 | Aug 19, 2014, 05:08 PM |
| Anderson Bruce G. | VP, US Sales and Marketing | Aug 18, 2014 | Sale | $10.52 | 10,000 | 105,182 | 34,564 | Aug 19, 2014, 05:08 PM |
| Burris Jeffrey W | Vice President & Gen. Counsel | Aug 15, 2014 | Option Exercise | $10.43 | 3,355 | 34,993 | 95,221 | Aug 19, 2014, 05:06 PM |
| Burris Jeffrey W | Vice President & Gen. Counsel | Aug 15, 2014 | Option Exercise | $7.00 | 5,000 | 35,000 | 98,576 | Aug 19, 2014, 05:06 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Aug 14, 2014 | Option Exercise | $9.73 | 119 | 1,158 | 228,728 | Aug 15, 2014, 05:01 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Aug 13, 2014 | Option Exercise | $9.73 | 9,881 | 96,142 | 238,490 | Aug 15, 2014, 05:01 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Aug 13, 2014 | Sale | $10.51 | 9,881 | 103,849 | 228,609 | Aug 15, 2014, 05:01 PM |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | Aug 14, 2014 | Sale | $10.50 | 119 | 1,250 | 228,609 | Aug 15, 2014, 05:01 PM |
| Burris Jeffrey W | Vice President & Gen. Counsel | Aug 13, 2014 | Option Exercise | $5.12 | 11,000 | 56,320 | 104,576 | Aug 14, 2014, 05:22 PM |
| Burris Jeffrey W | Vice President & Gen. Counsel | Aug 13, 2014 | Sale | $10.50 | 11,000 | 115,500 | 93,576 | Aug 14, 2014, 05:22 PM |
| RONALD C ELKINS | Director | Jul 29, 2014 | Sale | $9.67 | 2,500 | 24,175 | 83,500 | Jul 31, 2014, 05:10 PM |
| ANDERSON STEVEN G | President, CEO and Chairman | Jul 28, 2014 | Sale | $9.52 | 19,477 | 185,501 | 1,366,333 | Jul 29, 2014, 05:00 PM |
| Anderson Bruce G. | VP, US Sales and Marketing | Jul 28, 2014 | Option Exercise | $4.83 | 5,000 | 24,150 | 39,564 | Jul 29, 2014, 04:56 PM |
| Anderson Bruce G. | VP, US Sales and Marketing | Jul 28, 2014 | Sale | $9.48 | 5,000 | 47,424 | 35,564 | Jul 29, 2014, 04:56 PM |
| Horton Amy | Chief Accounting Officer | Jun 09, 2014 | Sale | $9.26 | 2,500 | 23,152 | 65,631 | Jun 11, 2014, 05:06 PM |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | May 16, 2014 | Sale | $8.61 | 8,952 | 77,088 | 101,528 | May 19, 2014, 05:02 PM |
| ANDERSON STEVEN G | President, CEO and Chairman | May 13, 2014 | Sale | $9.00 | 1,300 | 11,704 | 1,385,810 | May 14, 2014, 05:00 PM |
| ANDERSON STEVEN G | President, CEO and Chairman | May 12, 2014 | Sale | $9.00 | 29,223 | 263,051 | 1,387,110 | May 14, 2014, 05:00 PM |
| Anderson Bruce G. | VP, US Sales and Marketing | May 06, 2014 | Sale | $8.81 | 14,047 | 123,754 | 34,564 | May 06, 2014, 05:18 PM |
| Anderson Bruce G. | VP, US Sales and Marketing | May 02, 2014 | Sale | $8.94 | 2,823 | 25,244 | 51,382 | May 06, 2014, 05:18 PM |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | Mar 07, 2014 | Option Exercise | $9.87 | 1,739 | 17,164 | 228,609 | Mar 10, 2014, 05:27 PM |
| Horton Amy | Chief Accounting Officer | Mar 07, 2014 | Option Exercise | $9.87 | 521 | 5,142 | 68,131 | Mar 10, 2014, 05:26 PM |
| Gale David C | VP-Research and Development | Mar 07, 2014 | Option Exercise | $9.87 | 1,025 | 10,117 | 52,643 | Mar 10, 2014, 05:26 PM |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Mar 07, 2014 | Option Exercise | $9.87 | 1,217 | 12,012 | 110,480 | Mar 10, 2014, 05:26 PM |
| Burris Jeffrey W | Vice President & Gen. Counsel | Mar 07, 2014 | Option Exercise | $9.87 | 1,217 | 12,012 | 93,576 | Mar 10, 2014, 05:25 PM |
| Capps Scott B | VP-Clinical Research | Mar 07, 2014 | Option Exercise | $9.87 | 869 | 8,577 | 81,970 | Mar 10, 2014, 05:25 PM |
| ANDERSON STEVEN G | President, CEO and Chairman | Mar 07, 2014 | Option Exercise | $9.87 | 6,252 | 61,707 | 1,416,333 | Mar 10, 2014, 05:25 PM |
| Anderson Bruce G. | VP, US Sales and Marketing | Mar 07, 2014 | Option Exercise | $9.87 | 695 | 6,860 | 51,434 | Mar 10, 2014, 05:25 PM |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | Feb 24, 2014 | Option Exercise | $9.79 | 10,560 | 103,382 | 213,681 | Feb 26, 2014, 06:07 PM |
| Horton Amy | Chief Accounting Officer | Feb 24, 2014 | Option Exercise | $9.79 | 3,046 | 29,820 | 61,985 | Feb 26, 2014, 06:00 PM |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Feb 24, 2014 | Option Exercise | $9.79 | 7,322 | 71,682 | 100,030 | Feb 26, 2014, 05:57 PM |
| Capps Scott B | VP-Clinical Research | Feb 24, 2014 | Option Exercise | $9.79 | 5,200 | 50,908 | 72,839 | Feb 26, 2014, 05:56 PM |
| Burris Jeffrey W | Vice President & Gen. Counsel | Feb 24, 2014 | Option Exercise | $9.79 | 7,330 | 71,761 | 83,126 | Feb 26, 2014, 05:54 PM |
| ANDERSON STEVEN G | President, CEO and Chairman | Feb 24, 2014 | Option Exercise | $9.79 | 26,342 | 257,888 | 1,380,918 | Feb 26, 2014, 05:52 PM |
| Anderson Bruce G. | VP, US Sales and Marketing | Feb 24, 2014 | Option Exercise | $9.79 | 4,197 | 41,089 | 42,129 | Feb 26, 2014, 05:51 PM |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | Feb 21, 2014 | Option Exercise | $9.79 | 3,229 | 31,612 | 224,241 | Feb 25, 2014, 06:05 PM |
| Horton Amy | Chief Accounting Officer | Feb 21, 2014 | Option Exercise | $9.79 | 1,257 | 12,306 | 65,031 | Feb 25, 2014, 06:00 PM |
| Gale David C | VP-Research and Development | Feb 21, 2014 | Option Exercise | $9.79 | 1,972 | 19,306 | 43,668 | Feb 25, 2014, 05:57 PM |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Feb 21, 2014 | Option Exercise | $9.79 | 2,199 | 21,528 | 107,352 | Feb 25, 2014, 05:50 PM |
| Capps Scott B | VP-Clinical Research | Feb 21, 2014 | Option Exercise | $9.79 | 1,888 | 18,484 | 78,039 | Feb 25, 2014, 05:48 PM |
| Burris Jeffrey W | Vice President & Gen. Counsel | Feb 21, 2014 | Option Exercise | $9.79 | 2,199 | 21,528 | 90,456 | Feb 25, 2014, 05:45 PM |
| Anderson Bruce G. | VP, US Sales and Marketing | Feb 21, 2014 | Option Exercise | $9.79 | 1,903 | 18,630 | 46,326 | Feb 25, 2014, 05:42 PM |
| ANDERSON STEVEN G | President, CEO and Chairman | Feb 21, 2014 | Option Exercise | $9.79 | 8,075 | 79,054 | 1,407,260 | Feb 25, 2014, 05:37 PM |
| Horton Amy | Chief Accounting Officer | Feb 18, 2014 | Option Exercise | $10.71 | 1,827 | 19,567 | 58,540 | Feb 20, 2014, 05:25 PM |
| Horton Amy | Chief Accounting Officer | Feb 18, 2014 | Option Exercise | $8.70 | 2,250 | 19,575 | 60,367 | Feb 20, 2014, 05:25 PM |
| ANDERSON STEVEN G | President, CEO and Chairman | Dec 30, 2013 | Option Exercise | $10.94 | 50,696 | 554,614 | 1,366,906 | Dec 31, 2013, 12:04 PM |
| ANDERSON STEVEN G | President, CEO and Chairman | Dec 30, 2013 | Option Exercise | $8.70 | 63,750 | 554,625 | 1,417,602 | Dec 31, 2013, 12:04 PM |
| Capps Scott B | VP-Clinical Research | Nov 27, 2013 | Option Exercise | $9.06 | 25,000 | 226,500 | 93,303 | Dec 02, 2013, 05:43 PM |
| Capps Scott B | VP-Clinical Research | Nov 27, 2013 | Sale | $10.60 | 25,000 | 265,103 | 68,303 | Dec 02, 2013, 05:43 PM |
| Burris Jeffrey W | Vice President & Gen. Counsel | Nov 26, 2013 | Option Exercise | $7.00 | 5,000 | 35,000 | 84,099 | Nov 26, 2013, 05:03 PM |
| Burris Jeffrey W | Vice President & Gen. Counsel | Nov 26, 2013 | Sale | $10.50 | 5,000 | 52,500 | 79,099 | Nov 26, 2013, 05:03 PM |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Nov 11, 2013 | Option Exercise | $8.70 | 10,132 | 88,148 | 105,437 | Nov 13, 2013, 05:40 PM |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Nov 12, 2013 | Sale | $9.92 | 9,442 | 93,630 | 95,995 | Nov 13, 2013, 05:40 PM |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Nov 08, 2013 | Option Exercise | $9.90 | 4,277 | 42,342 | 95,305 | Nov 12, 2013, 05:19 PM |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Nov 08, 2013 | Option Exercise | $8.70 | 4,868 | 42,352 | 99,582 | Nov 12, 2013, 05:19 PM |
| Burris Jeffrey W | Vice President & Gen. Counsel | Nov 11, 2013 | Option Exercise | $7.00 | 5,000 | 35,000 | 84,099 | Nov 12, 2013, 05:15 PM |
| Burris Jeffrey W | Vice President & Gen. Counsel | Nov 11, 2013 | Sale | $10.00 | 5,000 | 50,000 | 79,099 | Nov 12, 2013, 05:15 PM |
| Gale David C | VP-Research and Development | Nov 08, 2013 | Option Exercise | $9.90 | 100 | 990 | 34,169 | Nov 12, 2013, 05:14 PM |
| Gale David C | VP-Research and Development | Nov 11, 2013 | Sale | $9.97 | 150 | 1,496 | 34,019 | Nov 12, 2013, 05:14 PM |
| ANDERSON STEVEN G | President, CEO and Chairman | Nov 07, 2013 | Sale | $9.47 | 23,375 | 221,448 | 1,358,120 | Nov 07, 2013, 05:13 PM |
| ANDERSON STEVEN G | President, CEO and Chairman | Nov 06, 2013 | Sale | $9.30 | 31,121 | 289,516 | 1,381,495 | Nov 07, 2013, 05:13 PM |
| ANDERSON STEVEN G | President, CEO and Chairman | Nov 05, 2013 | Sale | $9.39 | 45,504 | 427,228 | 1,412,616 | Nov 07, 2013, 05:13 PM |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | Nov 04, 2013 | Option Exercise | $8.70 | 12,500 | 108,750 | 220,012 | Nov 06, 2013, 05:16 PM |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | Nov 04, 2013 | Sale | $9.65 | 11,909 | 114,961 | 208,103 | Nov 06, 2013, 05:16 PM |
| Burris Jeffrey W | Vice President & Gen. Counsel | Nov 04, 2013 | Option Exercise | $7.00 | 5,000 | 35,000 | 84,099 | Nov 06, 2013, 05:11 PM |
| Burris Jeffrey W | Vice President & Gen. Counsel | Nov 04, 2013 | Sale | $9.53 | 5,000 | 47,650 | 79,099 | Nov 06, 2013, 05:11 PM |
| Horton Amy | Chief Accounting Officer | Nov 01, 2013 | Option Exercise | $9.46 | 6,207 | 58,718 | 58,117 | Nov 05, 2013, 05:15 PM |
| Horton Amy | Chief Accounting Officer | Nov 01, 2013 | Option Exercise | $8.70 | 6,750 | 58,725 | 64,324 | Nov 05, 2013, 05:15 PM |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | Oct 29, 2013 | Option Exercise | $9.00 | 24,166 | 217,494 | 207,512 | Oct 31, 2013, 05:06 PM |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | Oct 29, 2013 | Option Exercise | $8.70 | 25,000 | 217,500 | 231,678 | Oct 31, 2013, 05:06 PM |
| RONALD C ELKINS | Director | Oct 29, 2013 | Sale | $9.00 | 2,000 | 18,000 | 86,000 | Oct 31, 2013, 05:05 PM |
| Burris Jeffrey W | Vice President & Gen. Counsel | Oct 29, 2013 | Option Exercise | $7.00 | 5,000 | 35,000 | 84,099 | Oct 31, 2013, 05:05 PM |
| Burris Jeffrey W | Vice President & Gen. Counsel | Oct 29, 2013 | Sale | $9.00 | 5,000 | 45,000 | 79,099 | Oct 31, 2013, 05:05 PM |
| Anderson Bruce G. | VP, US Sales and Marketing | Aug 27, 2013 | Sale | $6.33 | 4,500 | 28,464 | 36,608 | Aug 28, 2013, 05:17 PM |
| RONALD C ELKINS | Director | Aug 05, 2013 | Sale | $7.02 | 2,000 | 14,041 | 88,000 | Aug 14, 2013, 05:54 PM |
| Horton Amy | Chief Accounting Officer | Aug 08, 2013 | Sale | $7.07 | 2,500 | 17,675 | 57,574 | Aug 09, 2013, 05:03 PM |
| McCall Ronald D | Director | Aug 01, 2013 | Sale | $7.10 | 6,000 | 42,588 | 137,162 | Aug 02, 2013, 04:49 PM |
| Burris Jeffrey W | Vice President & Gen. Counsel | Jul 12, 2013 | Option Exercise | $7.28 | 4,975 | 36,218 | 79,099 | Jul 16, 2013, 05:21 PM |
| Burris Jeffrey W | Vice President & Gen. Counsel | Jul 12, 2013 | Option Exercise | $4.83 | 7,500 | 36,225 | 84,074 | Jul 16, 2013, 05:21 PM |
| McCall Ronald D | Director | Jun 06, 2013 | Sale | $6.11 | 2,000 | 12,221 | 143,173 | Jun 07, 2013, 05:07 PM |
| McCall Ronald D | Director | Jun 05, 2013 | Sale | $6.19 | 2,000 | 12,380 | 145,162 | Jun 07, 2013, 05:07 PM |
| RONALD C ELKINS | Director | May 31, 2013 | Sale | $6.15 | 2,250 | 13,831 | 90,000 | Jun 03, 2013, 05:04 PM |
| Lang David P. | Sr. VP, Intl Sales & Marketing | Mar 07, 2013 | Option Exercise | $6.08 | 1,353 | 8,226 | 39,421 | Mar 11, 2013, 06:01 PM |
| Gale David C | VP-Research and Development | Mar 07, 2013 | Option Exercise | $6.08 | 2,030 | 12,342 | 34,269 | Mar 11, 2013, 05:51 PM |
| Horton Amy | Chief Accounting Officer | Mar 07, 2013 | Option Exercise | $6.08 | 827 | 5,028 | 60,074 | Mar 11, 2013, 05:48 PM |
| ANDERSON STEVEN G | President, CEO and Chairman | Mar 07, 2013 | Option Exercise | $6.08 | 8,697 | 52,878 | 1,458,120 | Mar 11, 2013, 05:42 PM |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Mar 07, 2013 | Option Exercise | $6.08 | 3,018 | 18,349 | 94,714 | Mar 11, 2013, 05:40 PM |
| Anderson Bruce G. | VP, US Sales and Marketing | Mar 07, 2013 | Option Exercise | $6.08 | 1,353 | 8,226 | 41,108 | Mar 11, 2013, 05:37 PM |
| Capps Scott B | VP-Clinical Research | Mar 07, 2013 | Option Exercise | $6.08 | 1,530 | 9,302 | 68,303 | Mar 11, 2013, 05:34 PM |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | Mar 07, 2013 | Option Exercise | $6.08 | 4,208 | 25,585 | 206,678 | Mar 11, 2013, 05:30 PM |
| Burris Jeffrey W | Vice President & Gen. Counsel | Mar 07, 2013 | Option Exercise | $6.08 | 2,799 | 17,018 | 76,297 | Mar 11, 2013, 05:26 PM |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | Feb 22, 2013 | Option Exercise | $6.12 | 5,891 | 36,053 | 210,886 | Feb 26, 2013, 05:41 PM |
| Horton Amy | Chief Accounting Officer | Feb 22, 2013 | Option Exercise | $6.12 | 1,322 | 8,091 | 60,901 | Feb 26, 2013, 05:37 PM |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Feb 22, 2013 | Option Exercise | $6.12 | 4,736 | 28,984 | 97,732 | Feb 26, 2013, 05:35 PM |
| Capps Scott B | VP-Clinical Research | Feb 22, 2013 | Option Exercise | $6.12 | 2,370 | 14,504 | 69,833 | Feb 26, 2013, 05:32 PM |
| Burris Jeffrey W | Vice President & Gen. Counsel | Feb 22, 2013 | Option Exercise | $6.12 | 4,402 | 26,940 | 79,096 | Feb 26, 2013, 05:29 PM |
| ANDERSON STEVEN G | President, CEO and Chairman | Feb 22, 2013 | Option Exercise | $6.12 | 13,895 | 85,037 | 1,466,817 | Feb 26, 2013, 05:26 PM |
| Anderson Bruce G. | VP, US Sales and Marketing | Feb 22, 2013 | Option Exercise | $6.12 | 2,163 | 13,238 | 42,461 | Feb 26, 2013, 05:23 PM |
| SEERY GERALD B | Sr. VP, Sales and Marketing | Nov 30, 2012 | Sale | $5.94 | 4,360 | 25,906 | 71,999 | Dec 03, 2012, 04:22 PM |
| McCall Ronald D | Director | Nov 14, 2012 | Sale | $5.72 | 6,000 | 34,322 | 137,162 | Nov 15, 2012, 05:44 PM |
| Gale David C | VP-Research and Development | Nov 08, 2012 | Option Exercise | $5.79 | 243 | 1,407 | 13,782 | Nov 13, 2012, 04:22 PM |
| RONALD C ELKINS | Director | Aug 27, 2012 | Sale | $5.34 | 3,000 | 16,031 | 82,250 | Aug 28, 2012, 05:20 PM |
| Salveson Jon W | Director | Jun 07, 2012 | Buy | $4.79 | 25,000 | 119,837 | 35,000 | Jun 11, 2012, 07:45 AM |
| RONALD C ELKINS | Director | Jun 01, 2012 | Sale | $4.57 | 3,000 | 13,704 | 85,250 | Jun 05, 2012, 04:49 PM |
| McCall Ronald D | Director | May 30, 2012 | Sale | $4.52 | 6,000 | 27,115 | 143,162 | May 31, 2012, 04:26 PM |
| McCall Ronald D | Director | May 29, 2012 | Sale | $4.57 | 4,000 | 18,276 | 149,162 | May 31, 2012, 04:26 PM |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | May 21, 2012 | Buy | $4.90 | 1,100 | 5,385 | 179,247 | May 23, 2012, 09:32 AM |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | May 21, 2012 | Buy | $4.90 | 1,000 | 4,900 | 5,000 | May 23, 2012, 09:32 AM |
| RONALD C ELKINS | Director | Feb 21, 2012 | Sale | $5.61 | 5,000 | 28,025 | 78,250 | Feb 22, 2012, 05:14 PM |
| Capps Scott B | VP-Clinical Research | Feb 16, 2012 | Option Exercise | $5.98 | 1,622 | 9,700 | 43,440 | Feb 21, 2012, 04:54 PM |
| Horton Amy | Chief Accounting Officer | Feb 16, 2012 | Option Exercise | $5.98 | 793 | 4,742 | 44,298 | Feb 21, 2012, 11:12 AM |
| SEERY GERALD B | Sr. VP, Sales and Marketing | Feb 16, 2012 | Option Exercise | $5.98 | 2,433 | 14,549 | 64,692 | Feb 21, 2012, 11:09 AM |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | Feb 16, 2012 | Option Exercise | $5.98 | 3,306 | 19,770 | 161,480 | Feb 21, 2012, 11:07 AM |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Feb 16, 2012 | Option Exercise | $5.98 | 1,972 | 11,793 | 64,530 | Feb 21, 2012, 11:03 AM |
| Burris Jeffrey W | Vice President & Gen. Counsel | Feb 16, 2012 | Option Exercise | $5.98 | 1,872 | 11,195 | 44,879 | Feb 21, 2012, 10:57 AM |
| ANDERSON STEVEN G | President, CEO and Chairman | Feb 16, 2012 | Option Exercise | $5.98 | 6,895 | 41,232 | 1,353,034 | Feb 21, 2012, 10:46 AM |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Feb 07, 2012 | Option Exercise | $5.86 | 18,673 | 109,424 | 66,502 | Feb 08, 2012, 05:14 PM |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Feb 07, 2012 | Option Exercise | $5.80 | 18,883 | 109,427 | 85,175 | Feb 08, 2012, 05:14 PM |
| SEERY GERALD B | Sr. VP, Sales and Marketing | Feb 03, 2012 | Option Exercise | $5.85 | 21,099 | 123,429 | 67,125 | Feb 07, 2012, 03:46 PM |
| SEERY GERALD B | Sr. VP, Sales and Marketing | Feb 03, 2012 | Option Exercise | $5.80 | 21,300 | 123,434 | 88,224 | Feb 07, 2012, 03:46 PM |
| HEACOX ALBERT E | Sr. VP Research and Devl | Dec 31, 2011 | Option Exercise | $4.80 | 2,433 | 11,678 | 110,144 | Jan 04, 2012, 04:10 PM |
| RONALD C ELKINS | Director | Dec 06, 2011 | Sale | $4.56 | 3,000 | 13,681 | 84,950 | Dec 07, 2011, 04:09 PM |
| McCall Ronald D | Director | Nov 22, 2011 | Sale | $4.35 | 10,000 | 43,500 | 143,162 | Nov 23, 2011, 11:25 AM |
| ANDERSON STEVEN G | President, CEO and Chairman | Nov 18, 2011 | Sale | $4.49 | 5,000 | 22,464 | 1,369,929 | Nov 21, 2011, 04:22 PM |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | Nov 21, 2011 | Buy | $4.34 | 4,000 | 17,355 | 4,000 | Nov 21, 2011, 04:19 PM |
| SEERY GERALD B | Sr. VP, Sales and Marketing | Aug 19, 2011 | Option Exercise | $4.97 | 12,358 | 61,419 | 66,924 | Aug 23, 2011, 01:26 PM |
| SEERY GERALD B | Sr. VP, Sales and Marketing | Aug 19, 2011 | Option Exercise | $4.25 | 21,099 | 89,671 | 79,282 | Aug 23, 2011, 01:26 PM |
| HEACOX ALBERT E | Sr. VP Research and Devl | Aug 15, 2011 | Option Exercise | $5.33 | 12,319 | 65,660 | 112,577 | Aug 17, 2011, 10:32 AM |
| HEACOX ALBERT E | Sr. VP Research and Devl | Aug 15, 2011 | Option Exercise | $4.25 | 15,450 | 65,663 | 124,896 | Aug 17, 2011, 10:32 AM |
| ANDERSON STEVEN G | President, CEO and Chairman | Aug 09, 2011 | Option Exercise | $5.44 | 49,609 | 269,873 | 1,374,929 | Aug 11, 2011, 02:06 PM |
| ANDERSON STEVEN G | President, CEO and Chairman | Aug 09, 2011 | Option Exercise | $4.25 | 63,500 | 269,875 | 1,424,538 | Aug 11, 2011, 02:06 PM |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Jul 26, 2011 | Option Exercise | $5.67 | 10,313 | 58,475 | 66,292 | Jul 28, 2011, 02:02 PM |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Jul 26, 2011 | Option Exercise | $4.25 | 13,760 | 58,480 | 76,605 | Jul 28, 2011, 02:02 PM |
| SEERY GERALD B | Sr. VP, Sales and Marketing | Jul 14, 2011 | Option Exercise | $4.25 | 101 | 429 | 58,284 | Jul 15, 2011, 05:06 PM |
| SEERY GERALD B | Sr. VP, Sales and Marketing | Jul 13, 2011 | Option Exercise | $4.25 | 300 | 1,275 | 58,483 | Jul 15, 2011, 05:06 PM |
| SEERY GERALD B | Sr. VP, Sales and Marketing | Jul 13, 2011 | Sale | $6.00 | 300 | 1,800 | 58,183 | Jul 15, 2011, 05:06 PM |
| SEERY GERALD B | Sr. VP, Sales and Marketing | Jul 14, 2011 | Sale | $6.00 | 101 | 606 | 58,183 | Jul 15, 2011, 05:06 PM |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | Jul 07, 2011 | Option Exercise | $5.91 | 13,790 | 81,499 | 164,786 | Jul 11, 2011, 09:11 AM |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | Jul 07, 2011 | Option Exercise | $4.25 | 17,200 | 73,100 | 178,576 | Jul 11, 2011, 09:11 AM |
| Horton Amy | Chief Accounting Officer | Jul 07, 2011 | Option Exercise | $5.91 | 6,472 | 38,250 | 45,091 | Jul 11, 2011, 09:09 AM |
| Horton Amy | Chief Accounting Officer | Jul 07, 2011 | Option Exercise | $4.25 | 9,000 | 38,250 | 51,563 | Jul 11, 2011, 09:09 AM |
| RONALD C ELKINS | Director | May 05, 2011 | Sale | $5.40 | 4,000 | 21,613 | 77,512 | May 09, 2011, 04:26 PM |
| Benson James | Director | May 04, 2011 | Option Exercise | $5.00 | 10,000 | 50,000 | 50,000 | May 06, 2011, 04:34 PM |
| Benson James | Director | May 04, 2011 | Sale | $5.43 | 10,000 | 54,289 | 40,000 | May 06, 2011, 04:34 PM |
| BEVEVINO DANIEL J | Director | May 05, 2011 | Option Exercise | $5.00 | 10,000 | 50,000 | 45,000 | May 06, 2011, 04:25 PM |
| BEVEVINO DANIEL J | Director | May 05, 2011 | Sale | $5.37 | 10,000 | 53,696 | 35,000 | May 06, 2011, 04:25 PM |
| ACKERMAN THOMAS F | Director | May 03, 2011 | Option Exercise | $5.00 | 10,000 | 50,000 | 45,000 | May 05, 2011, 04:28 PM |
| ACKERMAN THOMAS F | Director | May 03, 2011 | Sale | $5.53 | 10,000 | 55,296 | 35,000 | May 05, 2011, 04:28 PM |
| ANDERSON STEVEN G | President, CEO and Chairman | Apr 26, 2011 | Option Exercise | $5.66 | 8,886 | 50,295 | 1,361,038 | Apr 28, 2011, 02:31 PM |
| ANDERSON STEVEN G | President, CEO and Chairman | Apr 26, 2011 | Option Exercise | $5.03 | 10,000 | 50,300 | 1,369,924 | Apr 28, 2011, 02:31 PM |
| McCall Ronald D | Director | Apr 13, 2011 | Option Exercise | $5.00 | 3,200 | 16,000 | 140,412 | Apr 14, 2011, 02:35 PM |
| ANDERSON STEVEN G | President, CEO and Chairman | Feb 19, 2011 | Option Exercise | $5.37 | 2,810 | 15,090 | 1,281,257 | Feb 22, 2011, 05:09 PM |
| Horton Amy | Chief Accounting Officer | Feb 19, 2011 | Option Exercise | $5.37 | 396 | 2,127 | 33,230 | Feb 22, 2011, 05:06 PM |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | Feb 19, 2011 | Option Exercise | $5.37 | 1,011 | 5,429 | 40,845 | Feb 22, 2011, 05:02 PM |
| SEERY GERALD B | Sr. VP, Sales and Marketing | Feb 19, 2011 | Option Exercise | $5.37 | 1,103 | 5,923 | 36,183 | Feb 22, 2011, 04:59 PM |
| HEACOX ALBERT E | Sr. VP Research and Devl | Feb 19, 2011 | Option Exercise | $5.37 | 1,178 | 6,326 | 87,446 | Feb 22, 2011, 04:53 PM |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | Feb 19, 2011 | Option Exercise | $5.37 | 1,652 | 8,871 | 129,709 | Feb 22, 2011, 04:48 PM |
| Burris Jeffrey W | Vice President & Gen. Counsel | Feb 04, 2011 | Option Exercise | $5.31 | 3,245 | 17,231 | 24,751 | Feb 08, 2011, 12:07 PM |
| McCall Ronald D | Director | Nov 15, 2010 | Sale | $5.81 | 3,000 | 17,430 | 137,212 | Nov 16, 2010, 04:58 PM |
| McCall Ronald D | Director | Nov 12, 2010 | Sale | $5.89 | 7,000 | 41,238 | 140,212 | Nov 16, 2010, 04:58 PM |
| RONALD C ELKINS | Director | Nov 12, 2010 | Sale | $6.00 | 2,000 | 12,008 | 81,442 | Nov 15, 2010, 04:38 PM |
| Capps Scott B | VP-Clinical Research | Jul 30, 2010 | Option Exercise | $5.36 | 1,622 | 8,694 | 29,395 | Aug 02, 2010, 04:50 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 03/20/2024 | 44,511 |
| GREEN ANDREW M | VP Regulatory | 03/15/2024 | 29,240 |
| GREEN ANDREW M | VP Regulatory | 03/14/2024 | 79,880 |
| Getz Matthew A | VP, Human Resources | 03/12/2024 | 99,719 |
| Horton Amy | VP, Chief Accounting Officer | 02/26/2024 | 43,259 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 02/26/2024 | 60,955 |
| Maney Rochelle L. | VP, Quality | 02/26/2024 | 46,259 |
| Holloway Jean F | SVP, General Counsel | 02/26/2024 | 57,529 |
| GREEN ANDREW M | VP Regulatory | 02/26/2024 | 47,982 |
| Davis John E | Chief Commercial Officer | 02/26/2024 | 70,158 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 02/27/2024 | 9,223 |
| Maney Rochelle L. | VP, Quality | 02/27/2024 | 7,339 |
| GREEN ANDREW M | VP Regulatory | 02/27/2024 | 8,350 |
| Horton Amy | VP, Chief Accounting Officer | 02/27/2024 | 6,446 |
| Davis John E | Chief Commercial Officer | 02/27/2024 | 11,583 |
| Mackin James P | President & CEO | 02/26/2024 | 625,080 |
| Holloway Jean F | SVP, General Counsel | 02/27/2024 | 9,620 |
| Horton Amy | VP, Chief Accounting Officer | 03/05/2024 | 21,568 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 03/01/2024 | 28,195 |
| Getz Matthew A | VP, Human Resources | 02/26/2024 | 46,218 |
| Getz Matthew A | VP, Human Resources | 02/27/2024 | 6,446 |
| Maney Rochelle L. | VP, Quality | 03/05/2024 | 21,662 |
| Mackin James P | President & CEO | 02/27/2024 | 95,939 |
| Holloway Jean F | SVP, General Counsel | 03/05/2024 | 44,559 |
| GREEN ANDREW M | VP Regulatory | 03/05/2024 | 21,718 |
| Getz Matthew A | VP, Human Resources | 03/05/2024 | 21,661 |
| Davis John E | Chief Commercial Officer | 03/05/2024 | 37,856 |
| Mackin James P | President & CEO | 03/05/2024 | 262,037 |
| Mackin James P | President & CEO | 03/05/2024 | 262,037 |
| Holloway Jean F | SVP, General Counsel | 03/05/2024 | 44,559 |
| Davis John E | Chief Commercial Officer | 03/05/2024 | 37,856 |
| Getz Matthew A | VP, Human Resources | 03/05/2024 | 21,661 |
| Maney Rochelle L. | VP, Quality | 03/05/2024 | 21,662 |
| GREEN ANDREW M | VP Regulatory | 03/05/2024 | 21,718 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 03/05/2024 | 28,195 |
| Horton Amy | VP, Chief Accounting Officer | 03/05/2024 | 21,568 |
| Tyrs Florian | VP, Global Operations | 02/27/2024 | 6,724 |
| Horton Amy | VP, Chief Accounting Officer | 02/27/2024 | 6,446 |
| Mackin James P | President & CEO | 02/27/2024 | 95,939 |
| Holloway Jean F | SVP, General Counsel | 02/27/2024 | 9,620 |
| Davis John E | Chief Commercial Officer | 02/27/2024 | 11,583 |
| Maney Rochelle L. | VP, Quality | 02/27/2024 | 7,339 |
| Getz Matthew A | VP, Human Resources | 02/27/2024 | 6,446 |
| GREEN ANDREW M | VP Regulatory | 02/27/2024 | 8,350 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 02/27/2024 | 9,223 |
| Horton Amy | VP, Chief Accounting Officer | 02/26/2024 | 43,907 |
| Mackin James P | President & CEO | 02/26/2024 | 634,729 |
| Holloway Jean F | SVP, General Counsel | 02/26/2024 | 58,381 |
| Maney Rochelle L. | VP, Quality | 02/26/2024 | 46,928 |
| Davis John E | Chief Commercial Officer | 02/26/2024 | 71,233 |
| Getz Matthew A | VP, Human Resources | 02/26/2024 | 46,887 |
| GREEN ANDREW M | VP Regulatory | 02/26/2024 | 48,711 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 02/26/2024 | 61,786 |
| Tyrs Florian | VP, Global Operations | 02/26/2024 | 18,103 |
| Holloway Jean F | SVP, General Counsel | 02/20/2024 | 66,537 |
| Horton Amy | VP, Chief Accounting Officer | 02/20/2024 | 31,976 |
| Davis John E | Chief Commercial Officer | 02/20/2024 | 48,219 |
| Maney Rochelle L. | VP, Quality | 02/20/2024 | 7,678 |
| Getz Matthew A | VP, Human Resources | 02/20/2024 | 31,976 |
| Tyrs Florian | VP, Global Operations | 02/20/2024 | 4,697 |
| Mackin James P | President & CEO | 02/20/2024 | 965,367 |
| Mackin James P | President & CEO | 02/20/2024 | 1,358,818 |
| Holloway Jean F | SVP, General Counsel | 01/02/2024 | 346,033 |
| Holloway Jean F | SVP, General Counsel | 01/02/2024 | 382,122 |
| Davis John E | Senior VP, Global Sales | 01/02/2024 | 221,061 |
| Davis John E | Senior VP, Global Sales | 01/02/2024 | 244,116 |
| Horton Amy | VP, Chief Accounting Officer | 12/15/2023 | 234,671 |
| Horton Amy | VP, Chief Accounting Officer | 12/15/2023 | 273,543 |
| Berry Lance A | Executive VP, CFO | 12/06/2023 | 750,001 |
| Horton Amy | VP, Chief Accounting Officer | 12/06/2023 | 360,006 |
| Horton Amy | VP, Chief Accounting Officer | 11/27/2023 | 30,643 |
| Horton Amy | VP, Chief Accounting Officer | 11/27/2023 | 36,431 |
| Tyrs Florian | VP, Global Operations | 08/08/2023 | 35,377 |
| THOMSON ROBERT C | VP Research & Development | 06/09/2023 | 79,402 |
| Maier Dennis B | SVP, Operations | 06/06/2023 | 248,163 |
| Getz Matthew A | VP, Human Resources | 06/07/2023 | 100,483 |
| Maier Dennis B | SVP, Operations | 03/02/2023 | 15,035 |
| Maney Rochelle L. | VP, Quality | 03/02/2023 | 11,011 |
| Horton Amy | VP, Chief Accounting Officer | 03/02/2023 | 9,415 |
| Getz Matthew A | VP, Human Resources | 03/02/2023 | 9,415 |
| Mackin James P | President & CEO | 03/02/2023 | 133,984 |
| GREEN ANDREW M | VP Regulatory | 03/02/2023 | 11,065 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 03/02/2023 | 18,790 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 03/02/2023 | 12,165 |
| Davis John E | Senior VP, Global Sales | 03/02/2023 | 15,035 |
| Holloway Jean F | SVP, General Counsel | 03/02/2023 | 12,165 |
| Horton Amy | VP, Chief Accounting Officer | 02/27/2023 | 18,359 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/27/2023 | 40,030 |
| Holloway Jean F | SVP, General Counsel | 02/27/2023 | 25,358 |
| Davis John E | Senior VP, Global Sales | 02/27/2023 | 30,961 |
| Maney Rochelle L. | VP, Quality | 02/27/2023 | 10,221 |
| Maney Rochelle L. | VP, Quality | 02/27/2023 | 11,360 |
| Maney Rochelle L. | VP, Quality | 02/28/2023 | 5,374 |
| GREEN ANDREW M | VP Regulatory | 02/27/2023 | 22,603 |
| Mackin James P | President & CEO | 02/27/2023 | 292,787 |
| Maier Dennis B | SVP, Operations | 02/27/2023 | 30,146 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 02/27/2023 | 30,236 |
| Getz Matthew A | VP, Human Resources | 02/27/2023 | 20,701 |
| Getz Matthew A | VP, Human Resources | 02/19/2023 | 19,642 |
| Getz Matthew A | VP, Human Resources | 02/17/2023 | 5,067 |
| Holloway Jean F | SVP, General Counsel | 02/19/2023 | 23,732 |
| Holloway Jean F | SVP, General Counsel | 02/17/2023 | 27,711 |
| Maney Rochelle L. | VP, Quality | 02/17/2023 | 5,626 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/19/2023 | 36,715 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/17/2023 | 8,865 |
| Maier Dennis B | SVP, Operations | 02/19/2023 | 19,642 |
| Maier Dennis B | SVP, Operations | 02/17/2023 | 5,305 |
| Horton Amy | VP, Chief Accounting Officer | 02/19/2023 | 19,055 |
| Horton Amy | VP, Chief Accounting Officer | 02/17/2023 | 5,067 |
| Horton Amy | VP, Chief Accounting Officer | 02/17/2023 | 212,101 |
| Horton Amy | VP, Chief Accounting Officer | 02/17/2023 | 253,553 |
| Mackin James P | President & CEO | 02/17/2023 | 38,250 |
| Mackin James P | President & CEO | 02/19/2023 | 149,260 |
| Davis John E | Senior VP, Global Sales | 02/19/2023 | 31,368 |
| Davis John E | Senior VP, Global Sales | 02/17/2023 | 8,181 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/14/2023 | 377,057 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/14/2023 | 421,874 |
| Mackin James P | President & CEO | 02/14/2023 | 671,222 |
| Mackin James P | President & CEO | 02/14/2023 | 747,207 |
| Davis John E | Senior VP, Global Sales | 02/13/2023 | 89,549 |
| Horton Amy | VP, Chief Accounting Officer | 12/14/2022 | 26,420 |
| Horton Amy | VP, Chief Accounting Officer | 12/14/2022 | 43,783 |
| Maney Rochelle L. | VP, Quality | 11/04/2022 | 2,393 |
| Maney Rochelle L. | VP, Quality | 08/16/2022 | 164,409 |
| Maier Dennis B | SVP, Operations | 08/09/2022 | 124,513 |
| SEMEDO ANTHONY B. | Director | 06/01/2022 | 149,997 |
| Salveson Jon W | Director | 06/01/2022 | 149,997 |
| Burbank Jeffrey H | Director | 06/01/2022 | 149,997 |
| Bullock James | Director | 06/01/2022 | 149,997 |
| Borgstrom Marna P | Director | 06/01/2022 | 149,997 |
| BEVEVINO DANIEL J | Director | 06/01/2022 | 149,997 |
| ACKERMAN THOMAS F | Director | 06/01/2022 | 149,997 |
| Maney Rochelle L. | VP, Quality | 03/08/2022 | 1,646 |
| Barthold Franz Peter | VP, Research & Development | 03/08/2022 | 1,544 |
| Maier Dennis B | Vice President, Operations | 03/05/2022 | 23,642 |
| Mackin James P | President & CEO | 03/05/2022 | 282,599 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 03/05/2022 | 46,547 |
| Horton Amy | VP, Chief Accounting Officer | 03/05/2022 | 24,553 |
| Holloway Jean F | SVP, General Counsel | 03/05/2022 | 39,020 |
| Davis John E | Senior VP, Global Sales | 03/05/2022 | 39,020 |
| Barthold Franz Peter | VP, Research & Development | 03/05/2022 | 13,057 |
| Maney Rochelle L. | VP, Quality | 02/27/2022 | 7,701 |
| Maier Dennis B | Vice President, Operations | 02/19/2022 | 5,006 |
| Mackin James P | President & CEO | 02/19/2022 | 56,871 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/19/2022 | 9,337 |
| Horton Amy | VP, Chief Accounting Officer | 02/19/2022 | 4,544 |
| Holloway Jean F | SVP, General Counsel | 02/19/2022 | 7,473 |
| Getz Matthew A | VP, Human Resources | 02/19/2022 | 4,331 |
| Davis John E | Senior VP, Global Sales | 02/19/2022 | 7,136 |
| Barthold Franz Peter | VP, Research & Development | 02/19/2022 | 6,266 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 02/17/2022 | 13,510 |
| Maney Rochelle L. | VP, Quality | 02/17/2022 | 17,133 |
| Maier Dennis B | Vice President, Operations | 02/17/2022 | 25,603 |
| Mackin James P | President & CEO | 02/17/2022 | 282,328 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/17/2022 | 43,995 |
| Horton Amy | VP, Chief Accounting Officer | 02/17/2022 | 24,815 |
| Holloway Jean F | SVP, General Counsel | 02/17/2022 | 62,633 |
| Getz Matthew A | VP, Human Resources | 02/17/2022 | 24,990 |
| Davis John E | Senior VP, Global Sales | 02/17/2022 | 35,613 |
| GREEN ANDREW M | VP Regulatory | 02/17/2022 | 10,080 |
| Barthold Franz Peter | VP, Research & Development | 02/17/2022 | 30,748 |
| Mackin James P | President & CEO | 02/09/2022 | 117,018 |
| Mackin James P | President & CEO | 02/10/2022 | 117,029 |
| Mackin James P | President & CEO | 02/09/2022 | 192,989 |
| Mackin James P | President & CEO | 02/10/2022 | 189,998 |
| Mackin James P | President & CEO | 02/08/2022 | 117,018 |
| Mackin James P | President & CEO | 02/08/2022 | 188,771 |
| Mackin James P | President & CEO | 02/07/2022 | 117,018 |
| Mackin James P | President & CEO | 02/07/2022 | 184,052 |
| Horton Amy | VP, Chief Accounting Officer | 12/09/2021 | 28,230 |
| Horton Amy | VP, Chief Accounting Officer | 12/08/2021 | 46,422 |
| Davis John E | Senior VP, Global Sales | 11/29/2021 | 10,398 |
| SEMEDO ANTHONY B. | Director | 11/29/2021 | 86,661 |
| SEMEDO ANTHONY B. | Director | 11/29/2021 | 260,400 |
| Maney Rochelle L. | VP, Quality | 11/04/2021 | 4,539 |
| Holloway Jean F | SVP, General Counsel | 08/31/2021 | 17,566 |
| McCall Ronald D | Director | 08/25/2021 | 145,266 |
| Maier Dennis B | Vice President, Operations | 08/23/2021 | 69,613 |
| McCall Ronald D | Director | 06/01/2021 | 129,992 |
| Davis John E | Senior VP, Global Sales | 05/25/2021 | 141,748 |
| Davis John E | Senior VP, Global Sales | 05/25/2021 | 377,880 |
| Horton Amy | VP, Chief Accounting Officer | 05/06/2021 | 63,041 |
| Horton Amy | VP, Chief Accounting Officer | 05/06/2021 | 171,930 |
| Holloway Jean F | SVP, General Counsel | 05/06/2021 | 67,768 |
| Holloway Jean F | SVP, General Counsel | 05/06/2021 | 201,849 |
| Maier Dennis B | Vice President, Operations | 03/12/2021 | 34,694 |
| Mackin James P | President & CEO | 03/12/2021 | 394,938 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 03/12/2021 | 77,004 |
| Horton Amy | VP, Chief Accounting Officer | 03/12/2021 | 43,562 |
| Holloway Jean F | SVP, General Counsel | 03/12/2021 | 67,184 |
| Davis John E | Senior VP, Global Sales | 03/12/2021 | 56,012 |
| Capps Scott B | VP, Clinical Research | 03/12/2021 | 34,895 |
| Holloway Jean F | SVP, General Counsel | 03/10/2021 | 42,797 |
| Barthold Franz Peter | VP, Research & Development | 03/08/2021 | 1,847 |
| Simpson Michael S | SVP, Regulatory Affairs and QA | 03/05/2021 | 7,430 |
| Maier Dennis B | Vice President, Operations | 03/05/2021 | 5,010 |
| Mackin James P | President & CEO | 03/05/2021 | 36,342 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 03/05/2021 | 8,774 |
| Horton Amy | VP, Chief Accounting Officer | 03/05/2021 | 5,523 |
| Holloway Jean F | SVP, General Counsel | 03/05/2021 | 7,308 |
| Davis John E | Senior VP, Global Sales | 03/05/2021 | 7,699 |
| Capps Scott B | VP, Clinical Research | 03/05/2021 | 5,010 |
| Barthold Franz Peter | VP, Research & Development | 03/05/2021 | 2,517 |
| Horton Amy | VP, Chief Accounting Officer | 03/01/2021 | 347,711 |
| Simpson Michael S | SVP, Regulatory Affairs and QA | 02/23/2021 | 22,869 |
| Maier Dennis B | Vice President, Operations | 02/23/2021 | 14,306 |
| Mackin James P | President & CEO | 02/23/2021 | 111,372 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/23/2021 | 31,432 |
| Horton Amy | VP, Chief Accounting Officer | 02/23/2021 | 15,729 |
| Holloway Jean F | VP, General Counsel | 02/23/2021 | 25,156 |
| Getz Matthew A | VP, Human Resources | 02/23/2021 | 14,306 |
| Davis John E | Senior VP, Global Sales | 02/23/2021 | 24,012 |
| Capps Scott B | VP, Clinical Research | 02/23/2021 | 14,306 |
| Barthold Franz Peter | VP, Research & Development | 02/23/2021 | 17,889 |
| Maier Dennis B | Vice President, Operations | 02/17/2021 | 142,876 |
| Maier Dennis B | Vice President, Operations | 02/17/2021 | 177,956 |
| Capps Scott B | VP, Clinical Research | 12/15/2020 | 99,700 |
| Capps Scott B | VP, Clinical Research | 12/15/2020 | 178,553 |
| Horton Amy | VP, Chief Accounting Officer | 12/14/2020 | 29,219 |
| Horton Amy | VP, Chief Accounting Officer | 12/14/2020 | 66,460 |
| McCall Ronald D | Director | 12/14/2020 | 101,069 |
| Maier Dennis B | Vice President, Operations | 12/14/2020 | 40,270 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 12/10/2020 | 166,160 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 12/10/2020 | 383,318 |
| Barthold Franz Peter | VP, Research & Development | 12/01/2020 | 13,688 |
| Horton Amy | VP, Chief Accounting Officer | 12/01/2020 | 66,460 |
| Horton Amy | VP, Chief Accounting Officer | 12/01/2020 | 138,503 |
| Maier Dennis B | Vice President, Operations | 11/02/2020 | 27,928 |
| Mackin James P | President & CEO | 09/16/2020 | 125,524 |
| Davis John E | Senior VP, Global Sales | 09/16/2020 | 166,459 |
| Bullock James | Director | 09/16/2020 | 166,273 |
| Mackin James P | President & CEO | 09/16/2020 | 125,524 |
| Salveson Jon W | Director | 06/01/2020 | 130,001 |
| MORGAN HARVEY | Director | 06/01/2020 | 130,001 |
| McCall Ronald D | Director | 06/01/2020 | 130,001 |
| Burbank Jeffrey H | Director | 06/01/2020 | 130,001 |
| Bullock James | Director | 06/01/2020 | 130,001 |
| Borgstrom Marna P | Director | 06/01/2020 | 130,001 |
| BEVEVINO DANIEL J | Director | 06/01/2020 | 130,001 |
| ACKERMAN THOMAS F | Director | 06/01/2020 | 130,001 |
| Horton Amy | VP, Chief Accounting Officer | 05/28/2020 | 71,415 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 05/22/2020 | 2,858 |
| McCall Ronald D | Director | 05/05/2020 | 39,219 |
| Maier Dennis B | Vice President, Operations | 03/12/2020 | 4,574 |
| Mackin James P | President & CEO | 03/12/2020 | 54,122 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 03/12/2020 | 10,383 |
| Horton Amy | VP, Chief Accounting Officer | 03/12/2020 | 5,910 |
| Holloway Jean F | VP, General Counsel | 03/12/2020 | 9,047 |
| Davis John E | Senior VP, Global Sales | 03/12/2020 | 7,550 |
| Capps Scott B | VP, Clinical Research | 03/12/2020 | 4,716 |
| Bogenschuetz Thomas J | VP, EMEA & General Manager | 03/12/2020 | 6,821 |
| Simpson Michael S | SVP, Regulatory Affairs and QA | 03/05/2020 | 16,404 |
| Maier Dennis B | Vice President, Operations | 03/05/2020 | 10,246 |
| Mackin James P | President & CEO | 03/05/2020 | 111,063 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 03/05/2020 | 18,299 |
| Horton Amy | VP, Chief Accounting Officer | 03/05/2020 | 9,598 |
| Holloway Jean F | VP, General Counsel | 03/05/2020 | 15,332 |
| Davis John E | Senior VP, Global Sales | 03/05/2020 | 15,332 |
| Capps Scott B | VP, Clinical Research | 03/05/2020 | 8,726 |
| Bogenschuetz Thomas J | VP, EMEA & General Manager | 03/05/2020 | 22,711 |
| McCall Ronald D | Director | 02/24/2020 | 123,340 |
| Mackin James P | President & CEO | 02/21/2020 | 261,974 |
| Horton Amy | VP, Chief Accounting Officer | 02/21/2020 | 53,893 |
| Holloway Jean F | VP, General Counsel | 02/21/2020 | 72,836 |
| Davis John E | Senior VP, Global Sales | 02/21/2020 | 73,805 |
| Capps Scott B | VP, Clinical Research | 02/21/2020 | 47,212 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/21/2020 | 91,359 |
| Holloway Jean F | VP, General Counsel | 01/21/2020 | 81,535 |
| Holloway Jean F | VP, General Counsel | 01/21/2020 | 253,744 |
| Holloway Jean F | VP, General Counsel | 01/16/2020 | 1,880 |
| Holloway Jean F | VP, General Counsel | 01/16/2020 | 5,850 |
| Holloway Jean F | VP, General Counsel | 12/12/2019 | 30,720 |
| Holloway Jean F | VP, General Counsel | 12/12/2019 | 78,000 |
| Capps Scott B | VP, Clinical Research | 11/26/2019 | 61,200 |
| Capps Scott B | VP, Clinical Research | 11/26/2019 | 179,108 |
| McCall Ronald D | Director | 11/19/2019 | 98,565 |
| Mackin James P | President & CEO | 11/13/2019 | 117,355 |
| MORGAN HARVEY | Director | 11/06/2019 | 53,476 |
| Horton Amy | VP, Chief Accounting Officer | 06/05/2019 | 29,170 |
| Capps Scott B | VP, Clinical Research | 05/31/2019 | 57,100 |
| McCall Ronald D | Director | 05/24/2019 | 44,499 |
| McCall Ronald D | Director | 05/23/2019 | 28,000 |
| McCall Ronald D | Director | 05/22/2019 | 78,346 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 05/13/2019 | 2,689 |
| Mackin James P | President & CEO | 05/03/2019 | 1,565,690 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 05/03/2019 | 101,996 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 05/03/2019 | 791,959 |
| Holloway Jean F | VP, General Counsel | 05/06/2019 | 83,425 |
| Holloway Jean F | VP, General Counsel | 05/06/2019 | 276,928 |
| Holloway Jean F | VP, General Counsel | 05/01/2019 | 102,400 |
| Holloway Jean F | VP, General Counsel | 05/01/2019 | 315,000 |
| Saurini Sherry M | VP, Quality | 03/14/2019 | 13,896 |
| McDermid James M | SVP, CHRO | 03/14/2019 | 22,216 |
| Maier Dennis B | Vice President, Operations | 03/14/2019 | 13,479 |
| Mackin James P | President & CEO | 03/14/2019 | 156,165 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 03/14/2019 | 29,762 |
| Horton Amy | VP, Chief Accounting Officer | 03/14/2019 | 16,891 |
| Holloway Jean F | VP, General Counsel | 03/14/2019 | 25,944 |
| Davis John E | Senior VP, Global Sales | 03/14/2019 | 21,635 |
| Capps Scott B | VP, Clinical Research | 03/14/2019 | 13,536 |
| Bogenschuetz Thomas J | VP, EMEA & General Manager | 03/14/2019 | 21,256 |
| Horton Amy | VP, Chief Accounting Officer | 03/06/2019 | 40,796 |
| Horton Amy | VP, Chief Accounting Officer | 03/06/2019 | 194,299 |
| Saurini Sherry M | VP, Quality | 03/02/2019 | 41,224 |
| Saurini Sherry M | VP, Quality | 03/01/2019 | 23,107 |
| McDermid James M | SVP, CHRO | 03/01/2019 | 14,880 |
| Mackin James P | President & CEO | 03/01/2019 | 240,659 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 03/01/2019 | 59,846 |
| Horton Amy | VP, Chief Accounting Officer | 03/01/2019 | 33,650 |
| Holloway Jean F | VP, General Counsel | 03/01/2019 | 44,728 |
| Davis John E | Senior VP, Global Sales | 03/01/2019 | 44,105 |
| Capps Scott B | VP, Clinical Research | 03/01/2019 | 32,284 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/22/2019 | 32,406 |
| McCall Ronald D | Director | 02/21/2019 | 181,390 |
| Holloway Jean F | VP, General Counsel | 02/22/2019 | 25,913 |
| Saurini Sherry M | VP, Quality | 02/19/2019 | 50,758 |
| Horton Amy | VP, Chief Accounting Officer | 02/19/2019 | 68,293 |
| Capps Scott B | VP, Clinical Research | 02/19/2019 | 68,005 |
| Davis John E | Senior VP, Global Sales | 02/19/2019 | 84,818 |
| Holloway Jean F | VP, General Counsel | 02/19/2019 | 84,588 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/19/2019 | 116,889 |
| Mackin James P | President & CEO | 02/19/2019 | 190,402 |
| Davis John E | Senior VP, Global Sales | 09/18/2018 | 32,130 |
| Davis John E | Senior VP, Global Sales | 09/18/2018 | 112,843 |
| Davis John E | Senior VP, Global Sales | 09/10/2018 | 119,408 |
| Holloway Jean F | VP, General Counsel | 09/10/2018 | 74,834 |
| RONALD C ELKINS | Director | 09/05/2018 | 172,672 |
| Capps Scott B | VP, Clinical Research | 08/30/2018 | 47,242 |
| Capps Scott B | VP, Clinical Research | 08/30/2018 | 215,921 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 08/15/2018 | 94,496 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 08/15/2018 | 531,994 |
| MORGAN HARVEY | Director | 08/14/2018 | 77,373 |
| MORGAN HARVEY | Director | 08/14/2018 | 79,776 |
| MORGAN HARVEY | Director | 08/13/2018 | 168,283 |
| Mackin James P | President & CEO | 08/14/2018 | 379,668 |
| Mackin James P | President & CEO | 08/13/2018 | 1,055,457 |
| Mackin James P | President & CEO | 08/15/2018 | 100,874 |
| Mackin James P | President & CEO | 08/14/2018 | 1,194,473 |
| Mackin James P | President & CEO | 08/13/2018 | 3,315,950 |
| Mackin James P | President & CEO | 08/15/2018 | 313,209 |
| Mackin James P | President & CEO | 08/10/2018 | 1,421,968 |
| McCall Ronald D | Director | 08/09/2018 | 89,900 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 08/10/2018 | 337,924 |
| Horton Amy | VP, Chief Accounting Officer | 08/10/2018 | 98,550 |
| Holloway Jean F | VP, General Counsel | 08/10/2018 | 15,420 |
| Holloway Jean F | VP, General Counsel | 08/10/2018 | 50,250 |
| RONALD C ELKINS | Director | 08/10/2018 | 38,393 |
| Holloway Jean F | VP, General Counsel | 08/07/2018 | 41,120 |
| Holloway Jean F | VP, General Counsel | 08/07/2018 | 130,000 |
| Davis John E | Senior VP, Global Sales | 07/26/2018 | 55,273 |
| Davis John E | Senior VP, Global Sales | 07/26/2018 | 105,121 |
| Holloway Jean F | VP, General Counsel | 07/23/2018 | 15,420 |
| Holloway Jean F | VP, General Counsel | 07/23/2018 | 45,750 |
| Saurini Sherry M | VP, Quality | 01/01/2018 | 3,101 |
| McDermid James M | SVP, CHRO | 01/01/2018 | 19,141 |
| Holloway Jean F | VP, General Counsel | 01/01/2018 | 13,978 |
| Davis John E | Senior VP, Global Sales | 07/06/2018 | 55,273 |
| Davis John E | Senior VP, Global Sales | 01/01/2018 | 21,235 |
| Davis John E | Senior VP, Global Sales | 07/06/2018 | 101,730 |
| Davis John E | Senior VP, Global Sales | 06/14/2018 | 126,788 |
| Davis John E | Senior VP, Global Sales | 06/14/2018 | 44,769 |
| RONALD C ELKINS | Director | 06/14/2018 | 144,446 |
| Horton Amy | VP, Chief Accounting Officer | 06/01/2018 | 28,350 |
| Horton Amy | VP, Chief Accounting Officer | 06/01/2018 | 63,168 |
| Davis John E | Senior VP, Global Sales | 06/01/2018 | 44,780 |
| Davis John E | Senior VP, Global Sales | 06/01/2018 | 122,444 |
| RONALD C ELKINS | Director | 05/30/2018 | 81,525 |
| Davis John E | Senior VP, Global Sales | 05/16/2018 | 44,780 |
| Davis John E | Senior VP, Global Sales | 05/16/2018 | 118,071 |
| RONALD C ELKINS | Director | 05/14/2018 | 247,500 |
| McCall Ronald D | Director | 05/08/2018 | 6,747 |
| McCall Ronald D | Director | 05/10/2018 | 50,782 |
| McCall Ronald D | Director | 05/09/2018 | 57,494 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 05/10/2018 | 2,530 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 05/09/2018 | 256,999 |
| Horton Amy | VP, Chief Accounting Officer | 05/09/2018 | 31,813 |
| Horton Amy | VP, Chief Accounting Officer | 05/09/2018 | 103,764 |
| Davis John E | Senior VP, Global Sales | 05/08/2018 | 44,780 |
| Davis John E | Senior VP, Global Sales | 05/08/2018 | 113,698 |
| RONALD C ELKINS | Director | 05/10/2018 | 126,500 |
| RONALD C ELKINS | Director | 05/08/2018 | 47,379 |
| RONALD C ELKINS | Director | 05/03/2018 | 48,000 |
| Davis John E | Senior VP, Global Sales | 05/03/2018 | 32,140 |
| Davis John E | Senior VP, Global Sales | 05/03/2018 | 80,016 |
| Davis John E | Senior VP, Global Sales | 04/17/2018 | 32,130 |
| Davis John E | Senior VP, Global Sales | 04/17/2018 | 76,659 |
| Holloway Jean F | VP, General Counsel | 04/01/2018 | 42,606 |
| Matthews William Robert | Senior VP, Operations, Quality | 03/05/2018 | 16,967 |
| McCall Ronald D | Director | 03/08/2018 | 105,448 |
| RONALD C ELKINS | Director | 03/08/2018 | 44,000 |
| Mackin James P | President & CEO | 03/05/2018 | 121,583 |
| McDermid James M | SVP, CHRO | 03/05/2018 | 19,093 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 03/05/2018 | 23,842 |
| Horton Amy | VP, Chief Accounting Officer | 03/05/2018 | 13,367 |
| Holloway Jean F | VP, General Counsel | 03/05/2018 | 19,571 |
| Davis John E | Senior VP, Global Sales | 03/05/2018 | 18,327 |
| Capps Scott B | VP, Clinical Research | 03/05/2018 | 11,624 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/19/2018 | 68,328 |
| Horton Amy | VP, Chief Accounting Officer | 02/19/2018 | 27,010 |
| Capps Scott B | VP, Clinical Research | 02/19/2018 | 40,990 |
| Mackin James P | President & CEO | 02/19/2018 | 173,868 |
| Matthews William Robert | Senior VP, Operations, Quality | 02/19/2018 | 21,590 |
| Mackin James P | President & CEO | 02/19/2018 | 139,430 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/19/2018 | 50,881 |
| Horton Amy | VP, Chief Accounting Officer | 02/19/2018 | 27,412 |
| Holloway Jean F | VP, General Counsel | 02/19/2018 | 34,255 |
| Davis John E | Senior VP, Global Sales | 02/19/2018 | 21,590 |
| Capps Scott B | VP, Clinical Research | 02/19/2018 | 27,758 |
| Capps Scott B | VP, Clinical Research | 02/13/2018 | 160,415 |
| Capps Scott B | VP, Clinical Research | 02/13/2018 | 160,425 |
| RONALD C ELKINS | Director | 12/15/2017 | 20,000 |
| Gale David C | VP, Research & Development | 11/16/2017 | 118,800 |
| Gale David C | VP, Research & Development | 11/16/2017 | 392,500 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 11/09/2017 | 154,332 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 11/08/2017 | 169,933 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 11/08/2017 | 630,550 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 11/09/2017 | 559,888 |
| Horton Amy | VP, Chief Accounting Officer | 11/08/2017 | 76,000 |
| RONALD C ELKINS | Director | 11/06/2017 | 19,030 |
| Benson James | Director | 10/02/2017 | 45,600 |
| Mackin James P | President & CEO | 09/06/2017 | 1,800,679 |
| Mackin James P | President & CEO | 09/05/2017 | 951,061 |
| RONALD C ELKINS | Director | 09/05/2017 | 22,000 |
| Benson James | Director | 07/03/2017 | 39,900 |
| Horton Amy | VP, Chief Accounting Officer | 06/27/2017 | 95,575 |
| Horton Amy | VP, Chief Accounting Officer | 06/27/2017 | 191,540 |
| McCall Ronald D | Director | 05/22/2017 | 127,938 |
| Benson James | Director | 04/03/2017 | 33,200 |
| Horton Amy | VP, Chief Accounting Officer | 02/26/2017 | 4,796 |
| Horton Amy | VP, Chief Accounting Officer | 02/26/2017 | 38,364 |
| Gale David C | VP, Research & Development | 02/26/2017 | 64,722 |
| Capps Scott B | VP, Clinical Research | 02/26/2017 | 64,722 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/26/2017 | 107,882 |
| Capps Scott B | VP, Clinical Research | 02/22/2017 | 116,836 |
| Capps Scott B | VP, Clinical Research | 02/22/2017 | 181,776 |
| Matthews William Robert | Senior VP, Operations, Quality | 02/19/2017 | 228,770 |
| Matthews William Robert | Senior VP, Operations, Quality | 02/19/2017 | 38,157 |
| Mackin James P | President & CEO | 02/19/2017 | 1,043,556 |
| Mackin James P | President & CEO | 02/19/2017 | 287,920 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/19/2017 | 321,092 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/19/2017 | 76,487 |
| Horton Amy | VP, Chief Accounting Officer | 02/19/2017 | 180,625 |
| Horton Amy | VP, Chief Accounting Officer | 02/19/2017 | 39,037 |
| Holloway Jean F | VP, General Counsel | 02/19/2017 | 228,770 |
| Holloway Jean F | VP, General Counsel | 02/19/2017 | 51,681 |
| Gale David C | VP, Research & Development | 02/19/2017 | 180,625 |
| Gale David C | VP, Research & Development | 02/19/2017 | 43,505 |
| Davis John E | Senior VP, Global Sales | 02/19/2017 | 228,770 |
| Davis John E | Senior VP, Global Sales | 02/19/2017 | 38,157 |
| Capps Scott B | VP, Clinical Research | 02/19/2017 | 180,625 |
| Capps Scott B | VP, Clinical Research | 02/19/2017 | 43,677 |
| Benson James | Director | 01/03/2017 | 38,200 |
| RONALD C ELKINS | Director | 11/23/2016 | 40,000 |
| RONALD C ELKINS | Director | 11/14/2016 | 37,302 |
| Benson James | Director | 10/31/2016 | 33,501 |
| RONALD C ELKINS | Director | 09/20/2016 | 18,000 |
| McCall Ronald D | Director | 09/15/2016 | 52,631 |
| Matthews William Robert | Senior VP, Operations, Quality | 09/13/2016 | 20,100 |
| Holloway Jean F | VP, General Counsel | 09/12/2016 | 51,081 |
| Holloway Jean F | VP, General Counsel | 09/12/2016 | 28,920 |
| Gale David C | VP, Research & Development | 09/12/2016 | 52,459 |
| Gale David C | VP, Research & Development | 09/12/2016 | 21,030 |
| RONALD C ELKINS | Director | 09/12/2016 | 17,249 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 09/09/2016 | 498,035 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 09/12/2016 | 51,629 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 09/12/2016 | 31,447 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 09/09/2016 | 202,217 |
| Horton Amy | VP, Chief Accounting Officer | 09/09/2016 | 35,057 |
| Horton Amy | VP, Chief Accounting Officer | 09/13/2016 | 52,410 |
| Benson James | Director | 09/09/2016 | 171,800 |
| Horton Amy | VP, Chief Accounting Officer | 07/26/2016 | 94,836 |
| Horton Amy | VP, Chief Accounting Officer | 07/26/2016 | 70,100 |
| RONALD C ELKINS | Director | 07/26/2016 | 28,000 |
| McCall Ronald D | Director | 06/01/2016 | 115,600 |
| Benson James | Director | 05/10/2016 | 61,100 |
| RONALD C ELKINS | Director | 04/15/2016 | 12,000 |
| RONALD C ELKINS | Director | 03/07/2016 | 22,360 |
| Mackin James P | President & CEO | 03/04/2016 | 50,324 |
| Mackin James P | President & CEO | 03/03/2016 | 58,806 |
| Gale David C | VP, Research & Development | 02/26/2016 | 4,385 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/26/2016 | 7,315 |
| Horton Amy | VP, Chief Accounting Officer | 02/26/2016 | 2,920 |
| Capps Scott B | VP, Clinical Research | 02/26/2016 | 4,385 |
| Gale David C | VP, Research & Development | 11/08/2013 | 990 |
| Gale David C | VP, Research & Development | 11/11/2013 | 1,496 |
| Saurini Sherry M | VP, Quality | 02/19/2016 | 54,211 |
| Matthews William Robert | Senior VP, Operations, Quality | 02/19/2016 | 95,375 |
| Mackin James P | President & CEO | 02/19/2016 | 435,036 |
| Mackin James P | President & CEO | 02/19/2016 | 68,065 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/19/2016 | 133,857 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/22/2016 | 38,378 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/19/2016 | 27,218 |
| Horton Amy | VP, Chief Accounting Officer | 02/19/2016 | 75,295 |
| Horton Amy | VP, Chief Accounting Officer | 02/19/2016 | 10,885 |
| Holloway Jean F | VP, General Counsel | 02/22/2016 | 30,706 |
| Holloway Jean F | VP, General Counsel | 02/19/2016 | 95,375 |
| Holloway Jean F | VP, General Counsel | 02/19/2016 | 15,575 |
| Gale David C | VP, Research & Development | 02/19/2016 | 75,295 |
| Gale David C | VP, Research & Development | 02/19/2016 | 16,323 |
| Davis John E | Senior VP, Global Sales | 02/19/2016 | 95,375 |
| Capps Scott B | VP, Clinical Research | 02/19/2016 | 75,295 |
| Capps Scott B | VP, Clinical Research | 02/19/2016 | 16,323 |
| Capps Scott B | VP, Clinical Research | 02/19/2016 | 72,450 |
| Capps Scott B | VP, Clinical Research | 02/19/2016 | 154,500 |
| Horton Amy | VP, Chief Accounting Officer | 02/17/2016 | 43,462 |
| Horton Amy | VP, Chief Accounting Officer | 02/17/2016 | 43,470 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/17/2016 | 61,322 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/18/2016 | 38,640 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/17/2016 | 61,341 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/18/2016 | 81,040 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/15/2016 | 50,355 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/12/2016 | 14,632 |
| Horton Amy | VP, Chief Accounting Officer | 02/15/2016 | 20,140 |
| Horton Amy | VP, Chief Accounting Officer | 02/12/2016 | 5,844 |
| Capps Scott B | VP, Clinical Research | 02/15/2016 | 29,807 |
| Capps Scott B | VP, Clinical Research | 02/12/2016 | 8,535 |
| Gale David C | VP, Research & Development | 02/15/2016 | 29,744 |
| Gale David C | VP, Research & Development | 02/12/2016 | 8,535 |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | 12/28/2015 | 4,830 |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | 12/28/2015 | 7,700 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 11/27/2015 | 51,106 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 11/30/2015 | 25,208 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 11/30/2015 | 13,439 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 11/27/2015 | 116,708 |
| Benson James | Director | 09/15/2015 | 56,346 |
| Benson James | Director | 09/11/2015 | 40,154 |
| Benson James | Director | 09/11/2015 | 32,414 |
| ANDERSON STEVEN G | Former Executive Chairman | 04/09/2015 | 452,033 |
| ANDERSON STEVEN G | Former Executive Chairman | 04/09/2015 | 587,193 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 03/07/2015 | 18,277 |
| Horton Amy | Chief Accounting Officer | 03/07/2015 | 5,329 |
| Gale David C | VP, Research & Development | 03/07/2015 | 10,962 |
| FRONK DAVID | VP, Regulatory Affairs | 03/07/2015 | 12,791 |
| Capps Scott B | VP, Clinical Research | 03/07/2015 | 9,133 |
| ANDERSON STEVEN G | Executive Chairman | 03/07/2015 | 57,479 |
| Anderson Bruce G. | VP, US Sales &Global Marketing | 03/07/2015 | 7,304 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/26/2015 | 14,890 |
| Capps Scott B | VP, Clinical Research | 02/26/2015 | 8,930 |
| ANDERSON STEVEN G | Executive Chairman | 02/26/2015 | 46,075 |
| FRONK DAVID | VP, Regulatory Affairs | 02/26/2015 | 10,420 |
| Horton Amy | Chief Accounting Officer | 02/26/2015 | 5,789 |
| Gale David C | VP, Research & Development | 02/26/2015 | 8,930 |
| Anderson Bruce G. | VP, US Sales &Global Marketing | 02/26/2015 | 8,930 |
| ANDERSON STEVEN G | Executive Chairman | 02/23/2015 | 620,274 |
| ANDERSON STEVEN G | Executive Chairman | 02/23/2015 | 620,287 |
| FRONK DAVID | VP, Regulatory Affairs | 02/16/2015 | 145,940 |
| FRONK DAVID | VP, Regulatory Affairs | 02/16/2015 | 145,950 |
| Mackin James P | President & CEO | 02/19/2015 | 339,152 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/19/2015 | 135,663 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/18/2015 | 60,138 |
| Lang David P. | VP, Int'l Sales & Marketing | 02/19/2015 | 81,389 |
| Horton Amy | Chief Accounting Officer | 02/19/2015 | 54,263 |
| Horton Amy | Chief Accounting Officer | 02/18/2015 | 20,039 |
| Gale David C | VP, Research & Development | 02/19/2015 | 81,389 |
| Gale David C | VP, Research & Development | 02/18/2015 | 36,972 |
| FRONK DAVID | VP, Regulatory Affairs | 02/19/2015 | 94,963 |
| FRONK DAVID | VP, Regulatory Affairs | 02/18/2015 | 43,518 |
| Capps Scott B | VP, Clinical Research | 02/19/2015 | 81,389 |
| Capps Scott B | VP, Clinical Research | 02/18/2015 | 30,220 |
| ANDERSON STEVEN G | Executive Chairman | 02/18/2015 | 123,294 |
| ANDERSON STEVEN G | Executive Chairman | 02/19/2015 | 327,945 |
| Anderson Bruce G. | VP, US Sales &Global Marketing | 02/19/2015 | 81,389 |
| Anderson Bruce G. | VP, US Sales &Global Marketing | 02/18/2015 | 23,880 |
| Horton Amy | Chief Accounting Officer | 02/12/2015 | 8,527 |
| ANDERSON STEVEN G | Chairman | 02/12/2015 | 48,587 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 02/12/2015 | 21,329 |
| Anderson Bruce G. | VP, US Sales &Global Marketing | 02/12/2015 | 12,791 |
| FRONK DAVID | VP, Regulatory Affairs | 02/12/2015 | 14,934 |
| Gale David C | VP, Research & Development | 02/12/2015 | 12,791 |
| Capps Scott B | VP, Clinical Research | 02/12/2015 | 12,791 |
| Anderson Bruce G. | VP, US Sales &Global Marketing | 12/09/2014 | 35,499 |
| Anderson Bruce G. | VP, US Sales &Global Marketing | 12/09/2014 | 40,142 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 12/04/2014 | 278,899 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 12/04/2014 | 267,575 |
| Horton Amy | Chief Accounting Officer | 12/02/2014 | 87,562 |
| Horton Amy | Chief Accounting Officer | 12/02/2014 | 87,570 |
| Anderson Bruce G. | VP, US Sales &Global Marketing | 11/25/2014 | 132,757 |
| Anderson Bruce G. | VP, US Sales &Global Marketing | 11/25/2014 | 204,368 |
| Gale David C | VP, Research & Development | 11/08/2014 | 1,509 |
| RONALD C ELKINS | Director | 11/05/2014 | 40,320 |
| Benson James | Director | 11/03/2014 | 102,200 |
| Anderson Bruce G. | VP, US Sales &Global Marketing | 10/30/2014 | 52,905 |
| Anderson Bruce G. | VP, US Sales &Global Marketing | 10/30/2014 | 104,247 |
| Anderson Bruce G. | VP, US Sales and Marketing | 09/08/2014 | 51,200 |
| Anderson Bruce G. | VP, US Sales and Marketing | 09/08/2014 | 100,529 |
| ANDERSON STEVEN G | Chairman | 09/02/2014 | 201,502 |
| Anderson Bruce G. | VP, US Sales and Marketing | 08/25/2014 | 25,600 |
| Anderson Bruce G. | VP, US Sales and Marketing | 08/25/2014 | 50,255 |
| Anderson Bruce G. | VP, US Sales and Marketing | 08/18/2014 | 48,300 |
| Anderson Bruce G. | VP, US Sales and Marketing | 08/18/2014 | 105,182 |
| Burris Jeffrey W | Vice President & Gen. Counsel | 08/15/2014 | 34,993 |
| Burris Jeffrey W | Vice President & Gen. Counsel | 08/15/2014 | 35,000 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 08/14/2014 | 1,158 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 08/13/2014 | 96,142 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 08/13/2014 | 103,849 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 08/14/2014 | 1,250 |
| Burris Jeffrey W | Vice President & Gen. Counsel | 08/13/2014 | 56,320 |
| Burris Jeffrey W | Vice President & Gen. Counsel | 08/13/2014 | 115,500 |
| RONALD C ELKINS | Director | 07/29/2014 | 24,175 |
| ANDERSON STEVEN G | President, CEO and Chairman | 07/28/2014 | 185,501 |
| Anderson Bruce G. | VP, US Sales and Marketing | 07/28/2014 | 24,150 |
| Anderson Bruce G. | VP, US Sales and Marketing | 07/28/2014 | 47,424 |
| Horton Amy | Chief Accounting Officer | 06/09/2014 | 23,152 |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 05/16/2014 | 77,088 |
| ANDERSON STEVEN G | President, CEO and Chairman | 05/13/2014 | 11,704 |
| ANDERSON STEVEN G | President, CEO and Chairman | 05/12/2014 | 263,051 |
| Anderson Bruce G. | VP, US Sales and Marketing | 05/06/2014 | 123,754 |
| Anderson Bruce G. | VP, US Sales and Marketing | 05/02/2014 | 25,244 |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | 03/07/2014 | 17,164 |
| Horton Amy | Chief Accounting Officer | 03/07/2014 | 5,142 |
| Gale David C | VP-Research and Development | 03/07/2014 | 10,117 |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 03/07/2014 | 12,012 |
| Burris Jeffrey W | Vice President & Gen. Counsel | 03/07/2014 | 12,012 |
| Capps Scott B | VP-Clinical Research | 03/07/2014 | 8,577 |
| ANDERSON STEVEN G | President, CEO and Chairman | 03/07/2014 | 61,707 |
| Anderson Bruce G. | VP, US Sales and Marketing | 03/07/2014 | 6,860 |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | 02/24/2014 | 103,382 |
| Horton Amy | Chief Accounting Officer | 02/24/2014 | 29,820 |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 02/24/2014 | 71,682 |
| Capps Scott B | VP-Clinical Research | 02/24/2014 | 50,908 |
| Burris Jeffrey W | Vice President & Gen. Counsel | 02/24/2014 | 71,761 |
| ANDERSON STEVEN G | President, CEO and Chairman | 02/24/2014 | 257,888 |
| Anderson Bruce G. | VP, US Sales and Marketing | 02/24/2014 | 41,089 |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | 02/21/2014 | 31,612 |
| Horton Amy | Chief Accounting Officer | 02/21/2014 | 12,306 |
| Gale David C | VP-Research and Development | 02/21/2014 | 19,306 |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 02/21/2014 | 21,528 |
| Capps Scott B | VP-Clinical Research | 02/21/2014 | 18,484 |
| Burris Jeffrey W | Vice President & Gen. Counsel | 02/21/2014 | 21,528 |
| Anderson Bruce G. | VP, US Sales and Marketing | 02/21/2014 | 18,630 |
| ANDERSON STEVEN G | President, CEO and Chairman | 02/21/2014 | 79,054 |
| Horton Amy | Chief Accounting Officer | 02/18/2014 | 19,567 |
| Horton Amy | Chief Accounting Officer | 02/18/2014 | 19,575 |
| ANDERSON STEVEN G | President, CEO and Chairman | 12/30/2013 | 554,614 |
| ANDERSON STEVEN G | President, CEO and Chairman | 12/30/2013 | 554,625 |
| Capps Scott B | VP-Clinical Research | 11/27/2013 | 226,500 |
| Capps Scott B | VP-Clinical Research | 11/27/2013 | 265,103 |
| Burris Jeffrey W | Vice President & Gen. Counsel | 11/26/2013 | 35,000 |
| Burris Jeffrey W | Vice President & Gen. Counsel | 11/26/2013 | 52,500 |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 11/11/2013 | 88,148 |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 11/12/2013 | 93,630 |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 11/08/2013 | 42,342 |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 11/08/2013 | 42,352 |
| Burris Jeffrey W | Vice President & Gen. Counsel | 11/11/2013 | 35,000 |
| Burris Jeffrey W | Vice President & Gen. Counsel | 11/11/2013 | 50,000 |
| Gale David C | VP-Research and Development | 11/08/2013 | 990 |
| Gale David C | VP-Research and Development | 11/11/2013 | 1,496 |
| ANDERSON STEVEN G | President, CEO and Chairman | 11/07/2013 | 221,448 |
| ANDERSON STEVEN G | President, CEO and Chairman | 11/06/2013 | 289,516 |
| ANDERSON STEVEN G | President, CEO and Chairman | 11/05/2013 | 427,228 |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | 11/04/2013 | 108,750 |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | 11/04/2013 | 114,961 |
| Burris Jeffrey W | Vice President & Gen. Counsel | 11/04/2013 | 35,000 |
| Burris Jeffrey W | Vice President & Gen. Counsel | 11/04/2013 | 47,650 |
| Horton Amy | Chief Accounting Officer | 11/01/2013 | 58,718 |
| Horton Amy | Chief Accounting Officer | 11/01/2013 | 58,725 |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | 10/29/2013 | 217,494 |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | 10/29/2013 | 217,500 |
| RONALD C ELKINS | Director | 10/29/2013 | 18,000 |
| Burris Jeffrey W | Vice President & Gen. Counsel | 10/29/2013 | 35,000 |
| Burris Jeffrey W | Vice President & Gen. Counsel | 10/29/2013 | 45,000 |
| Anderson Bruce G. | VP, US Sales and Marketing | 08/27/2013 | 28,464 |
| RONALD C ELKINS | Director | 08/05/2013 | 14,041 |
| Horton Amy | Chief Accounting Officer | 08/08/2013 | 17,675 |
| McCall Ronald D | Director | 08/01/2013 | 42,588 |
| Burris Jeffrey W | Vice President & Gen. Counsel | 07/12/2013 | 36,218 |
| Burris Jeffrey W | Vice President & Gen. Counsel | 07/12/2013 | 36,225 |
| McCall Ronald D | Director | 06/06/2013 | 12,221 |
| McCall Ronald D | Director | 06/05/2013 | 12,380 |
| RONALD C ELKINS | Director | 05/31/2013 | 13,831 |
| Lang David P. | Sr. VP, Intl Sales & Marketing | 03/07/2013 | 8,226 |
| Gale David C | VP-Research and Development | 03/07/2013 | 12,342 |
| Horton Amy | Chief Accounting Officer | 03/07/2013 | 5,028 |
| ANDERSON STEVEN G | President, CEO and Chairman | 03/07/2013 | 52,878 |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 03/07/2013 | 18,349 |
| Anderson Bruce G. | VP, US Sales and Marketing | 03/07/2013 | 8,226 |
| Capps Scott B | VP-Clinical Research | 03/07/2013 | 9,302 |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | 03/07/2013 | 25,585 |
| Burris Jeffrey W | Vice President & Gen. Counsel | 03/07/2013 | 17,018 |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | 02/22/2013 | 36,053 |
| Horton Amy | Chief Accounting Officer | 02/22/2013 | 8,091 |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 02/22/2013 | 28,984 |
| Capps Scott B | VP-Clinical Research | 02/22/2013 | 14,504 |
| Burris Jeffrey W | Vice President & Gen. Counsel | 02/22/2013 | 26,940 |
| ANDERSON STEVEN G | President, CEO and Chairman | 02/22/2013 | 85,037 |
| Anderson Bruce G. | VP, US Sales and Marketing | 02/22/2013 | 13,238 |
| SEERY GERALD B | Sr. VP, Sales and Marketing | 11/30/2012 | 25,906 |
| McCall Ronald D | Director | 11/14/2012 | 34,322 |
| Gale David C | VP-Research and Development | 11/08/2012 | 1,407 |
| RONALD C ELKINS | Director | 08/27/2012 | 16,031 |
| Salveson Jon W | Director | 06/07/2012 | 119,837 |
| RONALD C ELKINS | Director | 06/01/2012 | 13,704 |
| McCall Ronald D | Director | 05/30/2012 | 27,115 |
| McCall Ronald D | Director | 05/29/2012 | 18,276 |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | 05/21/2012 | 5,385 |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | 05/21/2012 | 4,900 |
| RONALD C ELKINS | Director | 02/21/2012 | 28,025 |
| Capps Scott B | VP-Clinical Research | 02/16/2012 | 9,700 |
| Horton Amy | Chief Accounting Officer | 02/16/2012 | 4,742 |
| SEERY GERALD B | Sr. VP, Sales and Marketing | 02/16/2012 | 14,549 |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | 02/16/2012 | 19,770 |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 02/16/2012 | 11,793 |
| Burris Jeffrey W | Vice President & Gen. Counsel | 02/16/2012 | 11,195 |
| ANDERSON STEVEN G | President, CEO and Chairman | 02/16/2012 | 41,232 |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 02/07/2012 | 109,424 |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 02/07/2012 | 109,427 |
| SEERY GERALD B | Sr. VP, Sales and Marketing | 02/03/2012 | 123,429 |
| SEERY GERALD B | Sr. VP, Sales and Marketing | 02/03/2012 | 123,434 |
| HEACOX ALBERT E | Sr. VP Research and Devl | 12/31/2011 | 11,678 |
| RONALD C ELKINS | Director | 12/06/2011 | 13,681 |
| McCall Ronald D | Director | 11/22/2011 | 43,500 |
| ANDERSON STEVEN G | President, CEO and Chairman | 11/18/2011 | 22,464 |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | 11/21/2011 | 17,355 |
| SEERY GERALD B | Sr. VP, Sales and Marketing | 08/19/2011 | 61,419 |
| SEERY GERALD B | Sr. VP, Sales and Marketing | 08/19/2011 | 89,671 |
| HEACOX ALBERT E | Sr. VP Research and Devl | 08/15/2011 | 65,660 |
| HEACOX ALBERT E | Sr. VP Research and Devl | 08/15/2011 | 65,663 |
| ANDERSON STEVEN G | President, CEO and Chairman | 08/09/2011 | 269,873 |
| ANDERSON STEVEN G | President, CEO and Chairman | 08/09/2011 | 269,875 |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 07/26/2011 | 58,475 |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 07/26/2011 | 58,480 |
| SEERY GERALD B | Sr. VP, Sales and Marketing | 07/14/2011 | 429 |
| SEERY GERALD B | Sr. VP, Sales and Marketing | 07/13/2011 | 1,275 |
| SEERY GERALD B | Sr. VP, Sales and Marketing | 07/13/2011 | 1,800 |
| SEERY GERALD B | Sr. VP, Sales and Marketing | 07/14/2011 | 606 |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | 07/07/2011 | 81,499 |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | 07/07/2011 | 73,100 |
| Horton Amy | Chief Accounting Officer | 07/07/2011 | 38,250 |
| Horton Amy | Chief Accounting Officer | 07/07/2011 | 38,250 |
| RONALD C ELKINS | Director | 05/05/2011 | 21,613 |
| Benson James | Director | 05/04/2011 | 50,000 |
| Benson James | Director | 05/04/2011 | 54,289 |
| BEVEVINO DANIEL J | Director | 05/05/2011 | 50,000 |
| BEVEVINO DANIEL J | Director | 05/05/2011 | 53,696 |
| ACKERMAN THOMAS F | Director | 05/03/2011 | 50,000 |
| ACKERMAN THOMAS F | Director | 05/03/2011 | 55,296 |
| ANDERSON STEVEN G | President, CEO and Chairman | 04/26/2011 | 50,295 |
| ANDERSON STEVEN G | President, CEO and Chairman | 04/26/2011 | 50,300 |
| McCall Ronald D | Director | 04/13/2011 | 16,000 |
| ANDERSON STEVEN G | President, CEO and Chairman | 02/19/2011 | 15,090 |
| Horton Amy | Chief Accounting Officer | 02/19/2011 | 2,127 |
| FRONK DAVID | VP Reg. Affrs. and Qual Assur. | 02/19/2011 | 5,429 |
| SEERY GERALD B | Sr. VP, Sales and Marketing | 02/19/2011 | 5,923 |
| HEACOX ALBERT E | Sr. VP Research and Devl | 02/19/2011 | 6,326 |
| LEE DAVID ASHLEY | Exec. VP, COO and CFO | 02/19/2011 | 8,871 |
| Burris Jeffrey W | Vice President & Gen. Counsel | 02/04/2011 | 17,231 |
| McCall Ronald D | Director | 11/15/2010 | 17,430 |
| McCall Ronald D | Director | 11/12/2010 | 41,238 |
| RONALD C ELKINS | Director | 11/12/2010 | 12,008 |
| Capps Scott B | VP-Clinical Research | 07/30/2010 | 8,694 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR
STOCK BUYBACKS FOR
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.04%
1Q
06/30/2023
0.35%
2Q
03/31/2023
1.16%
3Q
12/31/2022
1.91%
4Q
09/30/2022
1.95%
5Q
06/30/2022
2.17%
6Q
03/31/2022
2.63%
7Q
12/31/2021
9.23%
8Q
09/30/2021
-7.99%
9Q
06/30/2021
5.02%
10Q
03/31/2021
5.58%
11Q
12/31/2020
5.90%
12Q
09/30/2020
7.88%
13Q
06/30/2020
9.01%
14Q
03/31/2020
9.38%
15Q
12/31/2019
7.94%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...